cytarabine has been researched along with Lymphoma in 450 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 187 (41.56) | 18.7374 |
| 1990's | 65 (14.44) | 18.2507 |
| 2000's | 80 (17.78) | 29.6817 |
| 2010's | 85 (18.89) | 24.3611 |
| 2020's | 33 (7.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, TH; Kessel, D; Khilanani, P | 1 |
| Chiba, A; Ebisawa, K; Honda, A; Kurokawa, M; Masamoto, Y; Okazaki, H | 1 |
| Buege, MJ; Caron, P; Dao, PH; Dixon, BN; Duggan, TA; Falchi, L; Hamilton, A; Hamlin, P; Jarrett, JC; Kumar, A; Leary, MH; Matasar, MJ; Moskowitz, A; Noy, A; Owens, CN; Pak, TK; Von Keudell, G; Younes, A; Zelenetz, AD | 1 |
| Ashkenazi, M; Avni, B; Grisariu, S; Lebel, E; Stepensky, P; Vainstein, V; Zimran, E | 1 |
| Bhojwani, D; Brown, P; Burke, MJ; Chang, BH; Chi, YY; Colace, SI; Florendo, E; Gossai, N; Heimbruch, K; Hermiston, ML; Heym, K; Hutchinson, RJ; Huynh, VT; Kaplan, JA; Malvar, J; Mody, R; O'Brien, TA; Place, AE; Pommert, L; Pulakanti, K; Rao, S; Schafer, ES; Shaw, PH; Sposto, R; Stelloh, C; Wayne, A; Ziegler, DS | 1 |
| Chen, X; Chu, J; Huang, H; Jiang, Y; Jin, Z; Li, C; Liu, S; Qian, C; Qu, C; Wu, D; Xu, T; Yang, H; Zhang, L; Zhang, X; Zhou, J; Zhu, Q | 1 |
| Avni, B; Gatt, ME; Goldschmidt, N; Grisaro, S; Gural, A; Lavie, D; Lebel, E; Linetski, E; Lossos, A; Makranz, C; Nachmias, B; Rosenberg, S; Saban, R; Shaulov, A; Siegal, T; Vainstein, V; Zimran, E | 1 |
| Balzarotti, M; Binder, M; Burger, E; Cabras, G; Cavalli, F; Celico, C; Cozens, K; Cwynarski, K; Deckert, M; Fabbri, A; Falautano, M; Ferranti, A; Ferreri, AJM; Finke, J; Fox, CP; Gørløv, JS; Hemmaway, C; Hertenstein, B; Hess, G; Ielmini, N; Ilariucci, F; Illerhaus, G; Johnson, PW; Keller, U; Krampera, M; Krause, SW; La Rosée, P; Linton, KM; Nonis, A; Orsucci, L; Panse, J; Pennese, E; Pisani, F; Politi, LS; Ponzoni, M; Pukrop, T; Pulczynski, E; Roth, A; Rummel, M; Schmoll, HJ; Schorb, E; Smith, J; Stilgenbauer, S; Thurner, L; Tucci, A; Zanni, M; Zucca, E | 1 |
| Allione, B; Angelillo, P; Cattaneo, C; Erbella, F; Facchetti, F; Ferreri, AJM; Flospergher, E; Foppoli, M; Lleshi, A; Pagani, C; Pecciarini, L; Ponzoni, M; Re, A; Rossi, G; Sassone, M; Spina, M; Steffanoni, S; Verga, L | 1 |
| Cohen, AL; Colman, H; Gelhard, S; Maxwell, A; Mendez, JS | 1 |
| Ahmad, I; Bambace, N; Bernard, L; Boisjoly, JA; Bouchard, P; Bourguignon, A; Chagnon, M; Cohen, S; Delisle, JS; Fleury, I; Kiss, T; Lachance, S; Mollica, L; Roy, DC; Roy, J; Sauvageau, G; Veilleux, O; Zehr, J | 1 |
| Berinstein, N; Crump, M; Drori, AK; Hicks, LK; Kridel, R; Liu, J; Prica, A; Suleman, A | 1 |
| Huang, Y; Jiang, H; Liang, Y; Qian, W; Xu, X; Yu, T; Yuan, X | 1 |
| Chang, Y; Fu, X; Li, L; Li, X; Lin, M; Nan, F; Shi, C; Sun, Z; Wang, X; Wu, X; Yan, J; Yu, H; Zhang, L; Zhang, M; Zhang, X; Zhou, Z; Zhu, L | 1 |
| Borawska, A; Dabrowska-Iwanicka, A; Domanska-Czyz, K; Druzd-Sitek, A; Konecki, R; Kotarska, M; Lapinska, G; Michalski, W; Mroz-Zycinska, E; Osiadacz, W; Osowiecki, M; Ostrowska, B; Paszkiewicz-Kozik, E; Poplawska, L; Romejko-Jarosinska, J; Rymkiewicz, G; Swierkowska, M; Szymanski, M; Tajer, J; Targonski, L; Walewski, J; Wojciechowska-Lampka, E; Wojewodzka-Mirocha, M | 1 |
| Agrawal, P; Bachanova, V; Berg, S; Bond, DA; Cai, J; Carter, J; Chang, J; Cleveland, J; David, KA; Epperla, N; Evens, AM; Folstad, M; Glantz, M; Goldlust, SA; Graber, J; Habib, A; Hossain, N; Kahl, B; Karmali, R; Kim, MS; Kim, SH; Kumar, P; Lin, Y; Major, A; Malecek, MK; Martin, P; Mier-Hicks, A; Naik, S; Ney, D; Ollila, TA; Rajakumar, P; Reddy, N; Rubenstein, J; Salman, S; Sieg, A; Singer, S; Smith, SM; Spurgeon, S; Strouse, C; Sundaram, S; Torka, P; Tsang, M; Vaca, R; Vendiola, JA; Venugopal, P; Zayac, A | 1 |
| Akita, T; Asano, K; Fudaba, H; Fujii, K; Hosoya, T; Ideguchi, M; Kakuta, K; Kambe, A; Katayama, K; Kawasaki, Y; Koizumi, S; Kurozumi, K; Nagashima, H; Nakayama, N; Natsumeda, M; Nishibuchi, I; Nishizaki, T; Sasayama, T; Shimabukuro, T; Sugiyama, K; Taguchi, K; Tanaka, K; Tsukamoto, Y; Yamasaki, F; Yasutomo, M; Yonezawa, U; Yoshida, K | 1 |
| Avni, B; Cohen, YI; Grisariu, S; Lebel, E; Shaulov, A; Stepensky, P; Zimran, E | 1 |
| Baba, S; Hiu, T; Imaizumi, Y; Izumo, T; Kato, T; Matsuo, A; Matsuo, T; Miyazaki, Y; Morimoto, S; Morofuji, Y; Niino, D; Okano, S; Ujifuku, K; Yamaguchi, S; Yoshida, K; Yoshida, M | 1 |
| Ahern, K; Correia De Farias, M; Pham, J; Sanderson, R; Walsh, K | 1 |
| Ashizawa, M; Fujiwara, SI; Genda, H; Hatano, K; Ikeda, T; Ito, S; Kanda, Y; Kawaguchi, SI; Mashima, K; Minakata, D; Morita, K; Muroi, K; Nagayama, T; Nakano, H; Ochi, SI; Oh, I; Ohmine, K; Sato, K; Toda, Y; Umino, K; Yamamoto, C; Yamasaki, R | 1 |
| Bazarbachi, A; Bou Akl, I; El-Cheikh, J; Ghaoui, N; Karout, L; Khalil, PB; Massoud, R; Matar, M; Zahreddine, A | 1 |
| Ding, B; Zhang, M; Zhang, YQ; Zhao, SX | 1 |
| Ballotta, L; Capria, S; Celentano, M; Ferrara, F; Marchesi, F; Mengarelli, A; Papa, E; Pedata, M; Picardi, A; Regazzo, G; Riccardi, C; Riemma, C; Terrenato, I; Trisolini, S | 1 |
| Beech, A; Bishton, MJ; Fox, CP; Glover, A; Griffiths, C; Martinez-Calle, N; McMillan, A; Richardson, F; Russell, N | 1 |
| Bode, U; Deckert, M; Egerer, G; Engert, A; Fimmers, R; Fliessbach, K; Herrlinger, U; Klockgether, T; Kowoll, A; Kroschinsky, F; Pels, H; Reichmann, H; Schackert, G; Schlegel, U; Schlömer, S; Schmidt-Wolf, IGH; Seidel, S; Vogt-Schaden, M | 1 |
| Kelsey, P; Kirkland, K; Lambert, J; Malladi, R; Morley, N; Paul, R; Pearce, R; Peniket, A; Perry, J; Snowden, JA | 1 |
| Avivi, I; Blumenthal, DT; Bokstein, F; Gibstein, L; Perry, C; Ram, R; Sarid, N; Weiss-Meilik, A | 1 |
| Blackwood, L; Harper, A; Smallwood, K | 1 |
| Bakunina, K; Bromberg, JEC; Dirven, L; Doorduijn, JK; Issa, S; van den Bent, MJ; van der Meulen, M | 1 |
| Akkurt, DM; Cinli, TA; Demir, I; Durusoy, SS; Gunes, AK; Ince, I; Ozkan, G; Pehlivan, M; Sarifakiogullari, S; Serin, I | 1 |
| Ahamed, SH; Bhattacharyya, R; Chang, KTE; Halepota, HF; Lam, JCM; Le Linn, Y; Lee, YT; Loh, AHP; Othman, MY; Tan, AM | 1 |
| Aoki, T; Hayakawa, F; Hikita, T; Iwamoto, E; Kagaya, Y; Kiyoi, H; Kunou, S; Oneyama, C; Sakamoto, A; Sanada, M; Shimada, K; Shimada, S; Takai, M | 1 |
| Birkmann, J; Blaudszun, AR; Bornhäuser, M; Ehninger, G; Fiedler, F; Fricke, S; Hänel, A; Hänel, M; Herbst, R; Kroschinsky, F; Kürzel, S; Schaefer-Eckart, K; Stahl, L | 1 |
| Chen, PY; Chuang, CC; Hsu, PW; Huang, YC; Jung, SM; Lin, TK; Tu, PH; Wei, KC; Yeh, TH | 1 |
| Armand, P; Batchelor, TT; Chen, YB; DeFilipp, Z; El-Jawahri, A; Li, S; Nayak, L; Wang, N | 1 |
| Bai, X; Chen, Y; Ji, N; Liu, F; Liu, J; Liu, Y; Qian, J; Qiu, X; Sun, S; Sun, X; Wang, Y; Zhu, H | 1 |
| Batlle, M; Feliu, E; Ferra, C; Garcia, O; Ibarra, G; Lopez, D; Moreno, M; Pineda, A; Ribera, JM; Sancho, JM; Sorigue, M; Tapia, G; Vives, S | 1 |
| Huh, J; Jo, JC; Kang, EH; Kim, JH; Kim, S; Lee, K; Lee, SW; Park, CS; Park, JS; Ryu, JS; Suh, C; Yoon, DH | 1 |
| Chiba, S; Hasegawa, Y; Hattori, K; Ishikawa, E; Kato, T; Kurita, N; Matsumura, A; Obara, N; Okoshi, Y; Sakata-Yanagimoto, M; Takano, S; Yamamoto, T; Yokoyama, Y | 1 |
| Elliott, J; Finotello, R | 1 |
| Birsen, R; Blanc, E; Bouscary, D; Burroni, B; Damotte, D; Deau, B; Dezamis, E; Edjlali, M; Franchi, P; Houillier, C; Kirova, Y; Le Ray, E; Legoff, M; Pallud, J; Pilorge, S; Soussain, C; Tamburini, J; Varlet, P; Vignon, M; Willems, L | 1 |
| Dünweber, A; Fridthjof, KS; Friis, LS; Gørløv, JS; Kampmann, P; Kjeldsen, L; Moser, C; Møller, T; Nexø, C; Nørskov, KH; Welinder, PC | 1 |
| Boehm, A; Keil, F; Koller, E; Menschel, E; Moestl, M; Noesslinger, T; Panny, M; Simanek, R | 1 |
| Billio, A; Borghero, C; Calimeri, T; Carli, G; Cascavilla, N; Centurioni, R; Chiusolo, P; Codeluppi, K; Fama, A; Fanin, R; Federici, I; Ferrero, S; Finotto, S; Gherlinzoni, F; Ghione, P; Giannoccaro, M; Lanza, F; Loseto, G; Marino, D; Matera, R; Mazzone, AM; Mosna, F; Olivieri, A; Olivieri, J; Orciuolo, E; Pelosini, M; Perali, G; Rattotti, S; Saraceni, F; Sgherza, N; Sica, S; Stefani, PM; Tisi, MC; Tomei, G; Zaja, F | 1 |
| Chang, Y; Duan, L; Fu, X; Li, L; Li, X; Li, Z; Nan, F; Sun, Z; Tian, L; Wang, X; Wu, J; Yan, J; Yu, H; Zhang, L; Zhang, M; Zhang, X | 1 |
| Ali, H; Budde, E; Chen, R; Forman, SJ; Herrera, AF; Mei, M; Mokhtari, S; Nademanee, A; Nakamura, R; Popplewell, L; Salhotra, A; Sandhu, K; Stiller, T; Zain, J | 1 |
| Chen, J; Huang, H; Jiang, Y; Jin, Z; Liu, S; Ruan, J; Wu, D; Xiao, X; Zhang, L; Zhang, X | 1 |
| Brendle, C; la Fougère, C; Nikolaou, K; Pfannenberg, C; Ripkens, S; Soekler, M; Stef, I; Stefan, N | 1 |
| Bradbury, PA; Chan, KK; Chen, BE; Cheung, M; Cheung, WY; Ding, K; Hay, AE; Kornelsen, EA; Leighl, NB; Mittmann, N; Ng, RCH; Pater, JL; Tu, D | 1 |
| Alexis, M; Amorim, S; Bay, JO; Chauchet, A; Chrétien, ML; Cluzeau, T; Contentin, N; Cornillon, J; Daguenet, E; de Latour, RP; Dorvaux, V; Gyan, E; Himberlin, C; Huynh, A; Lejeune, C; Mercier, M; Nicolas-Virelizier, E; Salles, G; Vallet, N | 1 |
| Belada, D; Malý, J; Motyčková, M; Smolej, L; Zák, P | 1 |
| Dys, P; Jurek, T; Rorat, M; Swiatek, B | 1 |
| Altuntaş, F; Bozdağ, SC; Demiriz, IŞ; Durgun, G; Koçubaba, S; Sarıca, A; Tekgündüz, E | 1 |
| Calandrelli, M; Capelli, D; Chiarucci, M; Gini, G; Inglese, E; Leoni, P; Mancini, G; Mancini, S; Montanari, M; Offidani, M; Olivieri, A; Poloni, A; Raggetti, G; Scortechini, I | 1 |
| Abrey, LE; Correa, DD; Curry, R; DeAngelis, LM; Grant, B; Grimm, S; Karimi, S; Lai, RK; Morris, PG; Omuro, A; Panageas, K; Raizer, JJ; Reiner, AS; Schiff, D; Shah, G; Yahalom, J | 1 |
| Asou, H; Kiyosawa, K; Maeda, K; Takeuchi, K; Taniai, H | 1 |
| Monteith, G; Parsons-Doherty, M; Poirier, VJ | 1 |
| Bai, B; Cai, QC; Cai, QQ; Gao, Y; Huang, HQ; Jiang, WQ; Wang, XX; Xia, YF; Xia, ZJ | 1 |
| Akutsu, M; Furukawa, Y; Hiraoka, N; Kano, Y; Kikuchi, J; Koyama, D; Mori, S; Nakamura, Y; Ueda, T; Uesawa, M; Wada, T; Yamauchi, T | 1 |
| Cen, J; Li, C; Liu, X; Ma, Y; Mei, K; Qian, L; Shen, J; Wang, Y; Zhao, D | 1 |
| Baldini, L; Balzarotti, M; Bobbio, F; Brandes, AA; Ciceri, F; Corazzelli, G; Ferreri, AJ; Ilariucci, F; Montanari, M; Reni, M; Spina, M; Stelitano, C; Zaja, F | 1 |
| Chataway, J; Cockerell, OC; Davagnanam, I; Patani, R; Ramsay, A; Samani, A | 1 |
| Atalla, A; Costa, LJ; dos Santos, KB; Hallack-Neto, AE; Pereira, J | 1 |
| D'Sa, S; Dorman, J; Marzolini, MA; Thomson, KJ | 1 |
| Engert, A; Kasenda, B; Skoetz, N; Zacher, J | 1 |
| Chang, Y; Fu, XR; Han, LJ; Li, L; Li, X; Ma, W; Sun, ZC; Wang, XH; Wu, JJ; Zhang, L; Zhang, MZ; Zhang, XD | 1 |
| Kato, S; Konuma, T; Oiwa-Monna, M; Takahashi, S; Tojo, A | 1 |
| Baetz, T; Buckstein, R; Chen, BE; Couban, S; Crump, M; Di Renzo, N; Djurfeldt, MS; Federico, M; Hay, AE; Howson-Jan, K; Imrie, KR; Kaizer, L; Kouroukis, CT; Kukreti, V; Kuruvilla, J; MacDonald, DA; Meyer, RM; Olney, HJ; Rubinger, M; Shepherd, LE; Sussman, J; Turner, AR; Voralia, M | 1 |
| Barriere, J; Borchiellini, D; Boscagli, A; Coso, D; Garnier, G; Gastaud, L; Gutnecht, J; Martin, N; Naman, H; Petit, E; Peyrade, F; Re, D; Rossignol, B; Saudes, L; Thyss, A | 1 |
| Eray, M; Haapasaari, KM; Haapasalo, H; Harjama, L; Jantunen, E; Karjalainen-Lindsberg, ML; Kuittinen, O; Kuitunen, H; Lehtinen, T; Leppä, S; Mannisto, S; Nousiainen, T; Soini, Y; Turpeenniemi-Hujanen, T; Vasala, K; Vornanen, M | 1 |
| Baetz, T; Chen, BE; Cheung, MC; Couban, S; Crump, M; Desjardins, P; Hassan, S; Hay, AE; Imrie, KR; Kouroukis, CT; Kukreti, V; Le, A; MacDonald, D; Meyer, RM; Mittmann, N; Risebrough, N; Shepherd, L; Song, Y; Sussman, J; Szwajcer, D | 1 |
| Ahmadzadeh, A; Hajizamani, S; Jalaeikhoo, H; Keyhani, M; Rahim, F; Sadeghi Hariri, B; Saki, N; Yekaninejad, MS | 1 |
| Gillem, J; Giuffrida, M; Krick, E | 1 |
| Amorim, S; Bouabdallah, R; Boumendil, A; Choquet, S; de Rosa, G; Delmer, A; Dreger, P; Faber, E; Facchini, L; Falzetti, F; Ferrara, F; Finel, H; Finke, J; Kobbe, G; Nicolas-Virelizier, E; Salles, G; Sayer, H; Scime, R; Sellner, L; Sureda, A; Vallisa, D; Yakoub-Agha, I; Zuffa, E | 1 |
| Czerw, T; Drozd-Sokolowska, J; Giebel, S; Halaburda, K; Holowiecki, J; Mendrek, W; Najda, J; Nowicki, M; Sadus-Wojciechowska, M; Sobczyk-Kruszelnicka, M; Wierzbowska, A | 1 |
| Barrié, M; Benouaich-Amiel, A; Chinot, O; Choquet, S; del Rio, MS; Delgadillo, D; Delwail, V; Ghesquieres, H; Gonzalez-Aguilar, A; Gressin, R; Gyan, E; Hoang-Xuan, K; Houillier, C; Huchet, A; Lacomblez, L; Lamy, T; Lebouvier-Sadot, S; Omuro, A; Soubeyran, P; Soussain, C; Taillandier, L; Tanguy, ML; Touitou, V | 1 |
| Li, M; Liu, L; Wang, Y; Xi, N; Xiao, X | 1 |
| Agresta, F; Ayton, R; Bennett, A; Bhattacharyya, P; Cooke, RE; Grigg, A; Lasica, M; Stern, C; Taylor, E | 1 |
| Bag, HG; Berber, I; Erkurt, MA; Kaya, E; Koroglu, M; Kuku, I; Nizam, I; Ozgul, M | 1 |
| Ai, W; Bence-Bruckler, I; Bierman, P; Braunschweig, I; Chen, AI; Comeau, T; Costa, LJ; Craig, M; Fay, JW; Flinn, I; Flowers, CR; Freytes, CO; Horwitz, ME; Kato, K; Laneuville, P; Le-Rademacher, J; Lill, M; Mason, J; Mineishi, S; Pasquini, MC; Pulsipher, MA; Rodriguez, TE; Rondelli, D; Shea, TC; Shore, TB; Smith, AJ; Vaughan, W; Waller, EK; Wang, Y; Xu, C; Yeager, AM; Yeh, RF | 1 |
| Hotta, T; Kubo, K; Miyazaki, Y; Murayama, T; Shimazaki, R; Tamura, K; Urabe, A; Usui, N | 1 |
| Bodaghi, B; Cassoux, N; Choquet, S; Costopoulos, M; Hoang-Xuan, K; Houillier, C; Le Cossec, C; Legarf-Tavernier, M; LeHoang, P; Nguyen, DT; Omuro, A; Soussain, C; Touitou, V | 1 |
| Ardeshna, KM; Foley, M; Kothari, J; Lambert, J; Linch, DC; Mackenzie, S; Morris, E; Peggs, KS; Thomson, K; Virchis, AE | 1 |
| Ashizawa, M; Fujiwara, S; Hatano, K; Ito, S; Kako, S; Kanda, Y; Kawasaki, Y; Mashima, K; Minakata, D; Muroi, K; Nakano, H; Oh, I; Ohmine, K; Okazuka, K; Sato, K; Sugimoto, M; Suzuki, T; Umino, K; Yamamoto, C; Yamasaki, R | 1 |
| Abboud, C; Cashen, AF; Ceriotti, C; DiPersio, J; Fletcher, T; Gao, F; Ghobadi, A; Stockerl-Goldstein, K; Vij, R | 1 |
| Baran, A; Barr, PM; Becker, MW; Friedberg, JW; Liesveld, JL; Milner, LA; Phillips, GL; Reid, RM; Wedow, L | 1 |
| Benger, A; Berinstein, NL; Chen, BE; Couban, S; Crump, M; Davison, K; Desjardins, P; Djurfeldt, MS; Hay, AE; Kaizer, L; Kukreti, V; Mangel, J; Shepherd, LE; Zhu, L | 1 |
| Bachanova, V; Brunstein, CG; Fair, C; Lazaryan, A; McClune, B; Rogosheske, J; Shanley, R | 1 |
| Fujiwara, SI; Hatano, K; Kanda, Y; Kawasaki, Y; Minakata, D; Muroi, K; Nakano, H; Oh, I; Ohmine, K; Okazuka, K; Sato, K; Sugimoto, M; Suzuki, T; Umino, K; Yamamoto, C; Yamasaki, R | 1 |
| Bajwa, RPS; Gerhardt, CA; Hagedoorn, M; Keim, MC; Lehmann, V; Olshefski, RS; Tuinman, MA; Winning, AM | 1 |
| Casper, J; Freund, M; Hilgendorf, I; Junghanss, C; Kahl, C; Leithaeuser, M; Steiner, B; Wolff, D | 1 |
| Cook, G; Crawley, C; Fields, P; Hickling, R; Hunter, A; Mahendra, P; Marcus, R; Peniket, A; Wilson, K | 1 |
| Galmarini, CM; Myhren, F; Sandvold, ML | 1 |
| Bonfanti, U; Comazzi, S; Lorenzo, MR; Marconato, L; Romanelli, G; Stefanello, D; Zini, E | 1 |
| Agarwal, RP; Fritzer-Szekeres, M; Graser, G; Grusch, M; Hidvegi, M; Jaeger, W; Krupitza, G; Lackner, A; Madlener, S; Ozsvar-Kozma, M; Saiko, P; Szekeres, T | 1 |
| Alvarez-Larran, A; Barca, EG; Deben, G; Garcia Vela, JA; Garcia, ES; Garcia-Cerecedo, T; Garcia-Marco, JA; Panizo, C; Penarrubia, MJ; Sancho, JM | 1 |
| Cioch, M; Dudzinski, M; Giebel, S; Hałasz, M; Holowiecka-Goral, A; Hołowiecki, J; Kos, K; Krawczyk-Kulis, M; Lehmann-Kopydłowska, A; Piszcz, J; Preisner, W; Stella-Holowiecka, B | 1 |
| Hofheinz, RD; Kripp, M | 1 |
| Swinnen, LJ | 1 |
| O'Brien, PC; Seymour, JF | 1 |
| Cascavilla, N; Crescimanno, A; Di Bartolomeo, P; Di Renzo, N; Lanza, F; Marcacci, G; Musso, M; Perrone, T; Pinto, A; Scalone, R | 1 |
| Biron, P; Blay, JY; Bosly, A; Casasnovas, O; Coiffier, B; Colin, P; Ferlay, C; Ghesquières, H; Haioun, C; Morel, P; Perol, D; Reman, O; Sebban, C; Tilly, H; Van den Neste, E | 1 |
| Baldini, L; Barbolini, E; Brugiatelli, M; Dell'Olio, M; Dondi, A; Federico, M; Giglio, G; Gobbi, PG; Luminari, S; Mannina, D; Merli, F; Polimeno, G; Stelitano, C | 1 |
| Jia, YQ; Meng, WT; Ni, X; Wen, Q; Zeng, Y | 1 |
| Cavalli, F; Cerny, T; Ferreri, AJ; Huitema, AD; Joerger, M; Krähenbühl, S; Reni, M; Schellens, JH; Zucca, E | 1 |
| Avilés, A; de Jesús Nambo, M; Huerta-Guzmán, J; Neri, N | 1 |
| Albo, C; Andrade, MA; Casado, P; Diaz, R; Esteban, P; Oujo, E; Torreira, C | 1 |
| Carrabba, MG; Chiara, A; Ciceri, F; Ferreri, AJ; Foppoli, M; Franzin, A; Politi, LS; Reni, M; Villa, E | 1 |
| Kowoll, A; Kuhnhenn, J; Ostermann, K; Pels, H; Schlegel, U | 1 |
| Chiba, S; Hasegawa, Y; Matsumura, A; Okoshi, Y; Sakamoto, N; Takano, S; Taoka, K | 1 |
| Cabanillas, F | 2 |
| Bamberg, M; Birnbaum, T; Fischer, L; Griesinger, F; Herrlinger, U; Hertenstein, B; Hundsberger, T; Jahnke, K; Kanz, L; Korfel, A; Leithäuser, M; Martus, P; Mergenthaler, HG; Nägele, T; Pietsch, T; Plasswilm, L; Rauch, M; Röth, A; Thiel, E; von Toll, T; Weller, M | 1 |
| Abboud, CN; Becker, MW; Bernstein, SH; Constine, LS; Friedberg, JW; Ifthikharuddin, JJ; Liesveld, JL; Loughner, JE; Milner, LA; Phillips, GL; Vesole, DH | 1 |
| Durrbach, A; Fermé, C; Hanna, C; Matta, C; Moise, L; Pilorge, S; Ribrag, V | 1 |
| Brion, A; Chauchet, A; Daguindau, E; Deconinck, E; Delaby, P; Fontan, J; Garnache-Ottou, F; Heczko, M; Helias, P; Larosa, F; Legrand, F; Schillinger, F; Vuillier, J | 1 |
| Corazzelli, G; Fava, S; Ferreri, AJ; Foppoli, M; Franzin, A; Licata, G; Paolini, R; Politi, LS; Ponzoni, M; Reni, M; Stelitano, C; Zaja, F; Zucca, E | 1 |
| Dreyling, M | 1 |
| Ashizawa, M; Kako, S; Kanda, Y; Kikuchi, M; Kimura, S; Nakasone, H; Nishida, J; Okuda, S; Oshima, K; Sakamoto, K; Sato, M; Terasako, K; Wada, H; Yamazaki, R | 1 |
| Choquet, S; del Rio, MS; Fourme, E; Glaisner, S; Hoang-Xuan, K; Janvier, M; Soussain, C | 1 |
| Hori, M; Nishida, H; Obara, K | 1 |
| Chen, ZT; Kong, PY; Li, DZ; Li, GH; Sun, JG; Wang, XX; Zhou, YB | 1 |
| Behler, CM; Cha, S; Damon, LE; Hwang, J; Issa, S; McDermott, M; O'Brien, J; Rubenstein, JL; Shuman, MA; Treseler, P; Valles, F; Wieduwilt, MJ | 1 |
| André, N; Ciccolini, J; Evrard, A; Iliadis, A; Lacarelle, B; M'Batchi, L; Mercier, C; Ouafik, L; Pourroy, B; Verschuur, A | 1 |
| Falchi, L; Ferranti, L; Gunnellini, M; Liberati, AM | 1 |
| Albiero, E; Bernardi, M; Castegnaro, S; Chieregato, K; Madeo, D; Rodeghiero, F; Visco, C; Zanon, C | 1 |
| Bucher, C; Buser, A; Gerull, S; Halter, J; Heim, D; O'Meara, A; Passweg, J; Stern, M | 1 |
| Cladera, A; Guinea, JM; Llorente, A; Mateos, C; Panizo, C; Salar, A; Sanchez-Gonzalez, B; Sancho, JM | 1 |
| Chmielowska, E; Chwieduk, A; Czerw, T; Giebel, S; Glowala-Kosinka, M; Grosicki, S; Holowiecki, J; Jurczyszyn, A; Kruzel, T; Mitrus, I; Najda, J; Nowara, E; Pasiarski, M; Sadus-Wojciechowska, M; Smagur, A | 1 |
| Levasseur, SD; White, VA; Wittenberg, LA | 1 |
| Han, X; He, X; Liu, P; Shi, Y; Yang, J | 1 |
| Hoffmann-Jagielska, M; Jagielski, D; Lechowski, R; Winnicka, A | 1 |
| Bondesan, P; Caracciolo, D; Cuttica, A; Di Nicola, M; Gallamini, A; Gianni, AM; Magni, M; Matteucci, P; Omedè, P; Pileri, A; Tarella, C; Zallio, F | 1 |
| DeAngelis, LM; Fisher, B; Schold, SC; Schultz, CJ; Seiferheld, W | 1 |
| Kagami, Y; Miura, K; Morishima, Y; Ogura, M; Suzuki, R; Taji, H; Takeuchi, T | 1 |
| Baron, B; Bogdhan, U; Chinot, O; De Beule, N; Delattre, JY; Frenay, M; Hildebrand, J; Hoang-Xuan, K; Soubeyran, P; Taillandier, L | 1 |
| Cox, J; Johnson, L; Lickliter, JD; McHugh, G; Tan, J; Wickham, NW; Wood, F; Wood, NJ | 1 |
| Cabanillas, F; Cox, JD; Dabaja, BS; Ha, CS; Kyritsis, AP; Levin, V; McLaughlin, P; Meyers, CA; Preti, HA; Pro, B; Seabrooke, LF; Wilder, RB; Yung, WK | 1 |
| BOSTWICK, L; EVANS, JS; MENGEL, GD; MUSSER, EA | 1 |
| Au, WY; Chan, EC; Kwong, YL; Leung, AY; Liang, R; Lie, AK; Ooi, GC; Siu, LL | 1 |
| Atasoy, A; Bode, U; Deckert, M; Diehl, V; Egerer, G; Engert, A; Fimmers, R; Glasmacher, A; Helmstaedter, C; Klockgether, T; Kroschinsky, F; Pels, H; Reichmann, H; Schackert, G; Schaller, C; Schlegel, U; Schmidt-Wolf, IG; Schulz, H; Vogt-Schaden, M; Zellner, A | 1 |
| Fehlings, T; Grehl, S; Kleuker, S; Pöttgen, C; Rauhut, F; Schmitz, A; Schwechheimer, K; Stüben, G; Stuschke, M; Wacker, HH; Wilhelm, H | 1 |
| Bolam, S; Child, JA; Davies, JM; Gilson, D; Howard, MR; Jalihal, SS; Mackie, MJ; McVerry, BA; Moreton, P; Morgan, GJ; Parapia, LA; Smith, GM; Williams, AT | 1 |
| Bird, KE; Cebra, CK; McDonough, SP; Saulez, MN; Schlipf, JW | 1 |
| Berthou, C; Colombat, P; Deconinck, E; Delwail, V; Foussard, C; Gaillard, F; Gressin, R; Harousseau, JL; Lucas, V; Milpied, N | 1 |
| Skandalis, A; Zomas, A | 1 |
| Ball, ED; Bashey, A; Carrier, E; Chen, YA; Corringham, S; Holman, P; Wang, EH | 1 |
| Caballero, MD; Cañizo, MC; López-Holgado, N; Martín, A; Mateos, MV; Miguel, JF; Pérez-Simón, JA | 1 |
| Alpdogan, O; Banerjee, D; Bertino, JR; Budak-Alpdogan, T; Moore, MA; Wang, E | 1 |
| Anghilieri, M; Cairoli, R; Marbello, L; Minola, E; Morra, E; Nosari, A; Ricci, F | 1 |
| Assari, S; Bennaceur, AL; Boccaccio, C; Bonnet, ML; Bourhis, JH; Decaudin, D; Farace, F; Greissenger, N; Guillier, M; Marracho, MC; Michon, J; Némati, F; Turhan, AG; Vantelon, JM | 1 |
| Ikarashi, Y; Imai, C; Kakihara, T; Tanaka, A; Uchiyama, M; Watanabe, A | 1 |
| Chang, WR; Fu, ZZ; Jin, ZM; Miao, M; Qiu, HY; Shen, YM; Sun, AN; Tang, XW; Wu, DP | 1 |
| Bauer, W; Fritzer-Szekeres, M; Grusch, M; Hoechtl, T; Horvath, Z; Illmer, C; Krupitza, G; Mader, RM; Madlener, S; Saiko, P; Schott, H; Szekeres, T | 1 |
| Aydin, F; Bektas, O; Kavgaci, H; Ozdemir, F; Yavuz, AA; Yavuz, MN; Yilmaz, M | 1 |
| Caballero, MD; del Cañizo, MC; López-Holgado, N; Martín, A; Pérez-Simón, JA; San Miguel, JF; Vázquez, L | 1 |
| Abboud, CN; Bernstein, SH; Chapman, M; Friedberg, JW; Ifthikharuddin, JJ; Johnson, V; Lancet, JE; Liesveld, JL; Phillips, GL; Spreng, E; Vesole, DH | 1 |
| Agarwal, RP; Bauer, W; Erlach, N; Fritzer-Szekeres, M; Grusch, M; Hoechtl, T; Horvath, Z; Illmer, C; Jaeger, W; Krupitza, G; Mader, RM; Madlener, S; Saiko, P; Schott, H; Szekeres, T | 1 |
| Pavlidis, N; Pentheroudakis, G | 1 |
| Fu, L; Kogoshi, H; Koyama, T; Nara, N; Tohda, S | 1 |
| Brevet, M; Damaj, G; Garidi, R; Gruson, B; Royer, B; Vaida, I | 1 |
| Giles, FJ; Huang, P; Keating, MJ; Pelicano, H; Xu, RH; Zhang, H | 1 |
| Horiike, S; Kanbayashi, Y; Matsumoto, Y; Mukoyama, N; Nishida, K; Nomura, K; Shimizu, D; Taniwaki, M | 1 |
| Derigs, G; Feuerhake, F; Finke, J; Frickhofen, N; Guttenberger, R; Ihorst, G; Illerhaus, G; Marks, R; Ostertag, C; Volk, B | 1 |
| Akutsu, M; Furukawa, Y; Izumi, T; Kano, Y; Kobayashi, H; Mano, H; Tsunoda, S | 1 |
| Ishigatsubo, Y; Kanamori, H; Kodama, F; Motomura, S; Tomita, N | 1 |
| Blechschmidt, M; Bornhäuser, M; Ehninger, G; Hänel, M; Hölig, K; Kroschinsky, F; Oelschlaegel, U; Ordemann, R; Platzbecker, U; Poppe-Thiede, K; Schaich, M | 1 |
| Braeckman, R; Chamberlain, M; Maria, B; Phuphanich, S | 1 |
| Bay, JO; Berthou, C; Bertrand, P; Brion, A; Camilleri-Broët, S; Colombat, P; Delepine, R; Delwail, V; Desablens, B; Lamy, T; Lemevel, A; Linassier, C; Rachieru, P | 1 |
| Arellano, M; Flowers, C; Heffner, LT; Hutcherson, D; Jo Lechowicz, M; Langston, A; Lonial, S; Waller, EK; Winton, E | 1 |
| Coutinho, F; Dantas, AA; Del Giglio, A; Manhani, AR | 1 |
| Ebeling, P; Metz, K; Moritz, T; Müller, S; Nowrousian, MR; Passon, J; Schütt, P; Seeber, S; Welt, A | 1 |
| Arber, C; Bucher, C; Buser, AS; Ghielmini, M; Gratwohl, A; Halter, J; Heim, D; Lohri, A; Meyer-Monard, S; Passweg, JR; Stern, M; Stussi, G; Tichelli, A | 1 |
| Assouad, S; Belhocine, R; Bourhis, JH; Brault, P; Chaoui, D; de Latour, RP; Decaudin, D; Heshmati, F; Legrand, O; Park, S; Rio, B | 1 |
| Ishizawa, K | 1 |
| Ference, SJ; Galor, A; Lee, MS; Peereboom, DM; Perez, VL; Singh, AD; Stevens, GH | 1 |
| Becker, A; Bode, U; Jaehde, U; Linnebank, M; Pels, H; Schlegel, U; Vezmar, S | 1 |
| Imataki, O; Kawakami, K; Tamai, Y | 1 |
| Abrey, LE; Correa, DD; DeAngelis, LM; Grant, B; Lai, RK; LaRocca, R; Raizer, JJ; Schiff, D; Shah, GD; Yahalom, J | 1 |
| Goldstein, DA; Tessler, HH | 1 |
| Benesch, M; Urban, C | 1 |
| Adams, DJ; Giles, F; Jacobsen, TF; Myhren, F; Rizzieri, DA; Sandvold, ML | 1 |
| Burchenal, JH; Dollinger, MR; Fox, JJ; Kreis, W | 1 |
| Loo, RV; O'Bryan, RM; Talley, RW; Tucker, WG | 1 |
| Akahoshi, Y; Kasai, C; Nishimoto, Y; Takeuchi, S | 1 |
| Anger, G; Fink, R; Höche, D | 1 |
| Kurowska, M; Rupniewska, ZM | 1 |
| Haren, JM; Kaneko, Y; Larson, RA; Rowley, JD; Variakojis, D | 1 |
| Bodey, GP; Burgess, MA; Cabanillas, F; Freireich, EJ | 1 |
| Archimbaud, E; Blanc, M; Bryon, PA; Coiffier, B; Felman, P; Ffrench, M; Fière, D; Guyotat, D; Rebattu, P; Vuvan, H | 1 |
| Hirai, H; Kusumoto, K; Miura, Y; Motoyoshi, K; Mutoh, Y; Ohda, M; Ozawa, K; Sakamoto, S; Suda, K; Takagi, S | 1 |
| David, R; Douay, L; Gorin, NC; Lecomte, D; Lopez, M; Najman, A; Oppenheimer, M; Parlier, Y; Salmon, C; Stachowiak, J | 2 |
| Stephens, CL | 1 |
| Yamada, K | 1 |
| Biron, P; Dutou, L; Ehrsam, A; Hervé, P; Le Mevel, A; Philip, I; Philip, T; Philippe, N; Plouvier, E; Souillet, G | 1 |
| Barlogie, B; Cabanillas, F; Kantarjian, H; McLaughlin, P; Plunkett, W; Riggs, S; Velasquez, W | 1 |
| Amadori, S; Avvisati, G; Mandelli, F; Martelli, M; Meloni, G; Monarca, B; Motta, M; Papa, G; Petti, MC; Salvagnini, M | 1 |
| Beaujean, F; Hartmann, O; Kalifa, C; Lemerle, J; Parmentier, C; Patte, C; Pein, F | 1 |
| Amadori, S; Avvisati, G; Fenu, S; Mandelli, F; Monarca, B; Papa, G; Petti, MC; Pulsoni, A | 1 |
| Postma, DS; Wallenborn, PA | 1 |
| Canellos, GP; Shipp, MA; Takvorian, RC | 1 |
| Bonmassar, E; Frati, L; Migliorati, G; Pastore, S; Riccardi, C | 1 |
| Koziner, B; Labriola, D; Lee, BJ; Little, C; Nisce, LZ; Oettgen, H; Sklaroff, R; Straus, DJ; Thaler, HT; Young, CW | 1 |
| Armata, J; Balwierz, W; Bogusławska-Jaworska, J; Ciepielewska, D; Kaczmarek-Kanold, M; Kościelniak, E; Ochocka, M; Radwańska, U; Sońta-Jakimczyk, D; Sroczyńska, M | 1 |
| Aherne, GW; Harvey, VJ; Johnston, A; Lister, TA; Piall, EM; Slevin, ML | 1 |
| Kubota, Y; Masaoka, T; Nakamura, H; Oguma, S; Shibata, H; Takubo, T; Tani, Y; Ueda, T | 1 |
| Feinstein, DI; Forman, SJ; Koehler, SC; Levine, AM; Liebman, H; Lukes, RJ; Meyer, PR; Paganini-Hill, A; Pockros, A | 1 |
| Griffin, TW; Rybak, ME; Shah, SS | 1 |
| Howell, SB; Pfeifle, CE | 1 |
| Alic, L; Haid, M | 1 |
| Galletti, F; Sturniolo, MG | 1 |
| Kim, TH; Ramsay, NK; Sklar, CA | 1 |
| Oguro, M; Takagi, T | 1 |
| Galbo, C; Lokich, J | 1 |
| Aherne, GW; Johnston, A; Lister, TA; Piall, EM; Slevin, ML | 1 |
| Beardsley, P; Egan, E; Fram, R; Kufe, D; Major, P; Rosenthal, D | 1 |
| Harada, T; Morikawa, K | 1 |
| Kuhlmann, J; Rietbrock, N; Wilke, J | 1 |
| Becker, H; Jürgenssen, OA; Krepler, P; Kundi, M; Mutz, I; Pichler, E; Radaszkiewicz, T; Reinartz, G; Schmidmeier, W; Urban, C | 1 |
| Castleberry, RP; Crist, WM; Gaddy, D; Holbrook, T; Malluh, A | 1 |
| Early, AP; Preisler, HD; Rustum, YM; Slocum, H | 1 |
| Chen, T; Doering, EJ; Falletta, JM; Moore, T; Pullen, J; Ramirez, I; Sullivan, MP; Trueworthy, R | 1 |
| Barzi, A; Bonmassar, E; Frati, L; Migliorati, G | 1 |
| Horikoshi, N; Ogawa, M | 1 |
| David, R; Duhamel, G; Gorin, NC; Najman, A; Parlier, Y; Petit, JC; Salmon, C; Stachowiak, J | 1 |
| Maruyama, Y; Young, JA | 1 |
| Richardson, VJ; Ryman, BE | 1 |
| Curt, GA; Richardson, VJ; Ryman, BE | 1 |
| Delfini, C; Izzi, T; Lucarelli, G; Porcellini, A | 1 |
| Abe, I; Hori, K; Saito, S; Sato, H; Suzuki, M | 1 |
| Khoo, RK; Ng, PR; Todd, D | 1 |
| Allen, TM; Gyorffy, E; Mausolf, S; McAllister, L | 1 |
| O'Neill, GJ; Stebbing, N | 1 |
| Bremer, AM; Hayakawa, T; Mogami, H; Ushio, Y; West, CR; Yamada, K | 1 |
| Akerman, M; Biörklund, A; Håkansson, L; Stenstam, B; Tropé, C | 1 |
| Hitzig, WH; Plüss, HJ; Sigg, C | 1 |
| O'Neill, GJ | 1 |
| Csoka, K; Larsson, R; Liliemark, J; Nygren, P | 1 |
| Chang, J; Crowther, D; Morgenstern, GR; Pettengell, R; Radford, JA; Rowlands, M; Scarffe, JH; Testa, NG; Woll, PJ; Young, R | 1 |
| Fuchsberger, P; Lakota, J | 1 |
| Amemiya, Y; Miura, Y; Muroi, K; Suzuki, T; Tomizuka, H | 1 |
| Ben-Shahar, M; Epelbaum, R; Haim, N | 1 |
| Tobinai, K | 1 |
| Allen, PD; Castenskiold, EC; Coldwell, RD; Collins, PW; Goldstone, AH; Kelsey, SM; Makin, HL; Newland, AC; Side, LE | 1 |
| Cantori, I; Ciniero, L; Leoni, P; Mancini, S; Masia, MC; Offidani, M; Olivieri, A; Ombrosi, L; Scalari, P | 1 |
| Xu, T | 1 |
| Fujii, H; Kuzuyama, Y; Maekawa, T; Nakagawa, H; Sonoda, Y | 1 |
| Furuta, H; Miyabe, K; Miyaguchi, M; Sakai, S; Takeda, J; Uozumi, N | 1 |
| Dreger, P; Eckstein, V; Haferlach, T; Jacobs, S; Löffler, H; Marquardt, P; Müller-Ruchholtz, W; Mülverstedt, T; Schmitz, N; Suttorp, M | 1 |
| Amador Del Valle, G; Daeschler, T; Felice, MP; Harousseau, JL; Milpied, N; Moreau, P; Richard, P; Richet, H | 1 |
| Daly, MB; Giguere, JK; Harden, EA; Harman, GH; Johnson, DB; Johnson, RA; Leff, RS; Mercier, RJ; Messerschmidt, GL; Snyder, MJ | 1 |
| Cabanillas, F; Hagemeister, FB; Hill, D; McLaughlin, P; Moore, DF; Rodriguez, MA; Romaguera, JE; Sarris, AH; Swan, F; Younes, A | 1 |
| Hashimoto, S; Hasuike, T; Hirai, M; Hirai, N; Kou, KR; Ohta, K; Ohta, T; Takekawa, K; Tanaka, K; Yamane, T | 1 |
| Baybordi, E; Ghavamzadeh, A; Jahani, M | 1 |
| Barbot, C; Jazwiec, B; Mahon, FX; Reiffers, J; Rice, A; Vanès, I | 1 |
| Chatterjee, R; Goldstone, AH; Katz, M; McGarrigle, HH; Mills, W | 1 |
| Cabanillas, F; Rodriguez, MA | 1 |
| Cabanillas, F; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Romaguera, J; Rubenstein, E; Swan, F; Tucker, S; Velasquez, WS | 1 |
| Breneman, JC; Cherlow, JM; Gaynon, PS; Grossman, NJ; Hammond, GD; Johnstone, HS; Kersey, JH; Sather, HN; Steinherz, PG; Trigg, ME | 1 |
| Gondo, H; Harada, M; Matsuishi, H; Omori, F; Otsuka, T; Shibuya, T; Taniguchi, S; Teshima, T; Yamano, Y; Yamazaki, K | 1 |
| Johnson, PW; Lister, TA; McCallum, P; Norton, AJ; Rohatiner, AZ; Sweetenham, JW | 1 |
| Carlson, K; Hagberg, H; Oberg, G; Simonsson, B; Smedmyr, B | 1 |
| Smith, RJ; Sweetenham, JW | 1 |
| Cabanillas, FC; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Romaguera, JE; Swan, F; Velasquez, W | 1 |
| Goldstone, AH; Linch, DC; Mills, W; Strang, J | 1 |
| DeAngelis, LM; Delattre, JY; Freilich, RJ; Monjour, A | 1 |
| Dräger, AM; Huijgens, PC; Schuurhuis, GJ; Teule, GJ; van Leeuwen-Stok, AE; Visser-Platier, AW | 1 |
| de Kreuk, AM; Dräger, AM; Huijgens, PC; Jonkhoff, AR; Legdeur, MC; Oberink, JW; Ossenkoppele, GJ; Schuurhuis, GJ; Westra, G; Zweegman, S | 1 |
| Fielding, AK; Goldstone, AH; Jamieson, E; Linch, DC; Sullivan, AM; Watts, MJ | 1 |
| Wiley, JS | 1 |
| Berdel, WE; Hoppe, B; Knauf, WU; Koenigsmann, MP; Notter, M; Oberberg, D; Reufi, B; Thiel, E | 1 |
| Abrey, LE; DeAngelis, LM; Yahalom, J | 1 |
| Clemens, M; Dichgans, J; Herrlinger, U; Kortmann, RD; Meyermann, R; Petersen, D; Schabet, M; Will, BE | 1 |
| Constine, LS; Hicks, DG; O'Keefe, R; Packman, CH; Rapoport, AP; Rosier, RN; Rowe, JM; Rubin, SJ | 1 |
| Bataille, B; Delwail, V | 1 |
| Hirose, M; Kuroda, Y | 1 |
| Fehse, N; Gutensohn, K; Hassan, HT; Kröger, N; Krüger, W; Lölliger, C; Zander, AR; Zeller, W | 1 |
| Hassan, HT; Hinz, T; Kroger, N; Zander, AR; Zeller, W | 1 |
| Anderlini, P; Andersson, B; Braunschweig, I; Champlin, R; Claxton, D; Cleary, K; Donato, M; Folloder, J; Gajewski, J; Giralt, S; Hagemeister, F; Khouri, I; Körbling, M; Mehra, R; Molldrem, J; Przepiorka, D; Samuels, B; Ueno, NT; van Besien, K | 1 |
| Hunter, N; Meyn, RE; Mirkovic, N; Story, MD | 1 |
| Bashir, R; Batchelor, T; Chamberlain, M; Cowens, W; Glantz, MJ; Gutheil, JC; Howell, SB; Jaeckle, KA; LaFollette, S; Lyter, D; Maria, BL; Phuphanich, S; Rogers, LR; Rozental, JR; Schiffer, C; Shapiro, W; Swinnen, L; Thomas, D | 1 |
| Devereux, S; Goldstone, AH; Ings, SJ; Leverett, D; Linch, DC; MacMillan, A; Watts, MJ | 1 |
| Diehl, V; Draube, A; Engert, A; Josting, A; Reiser, M; Rueffer, U; Söhngen, D; Tesch, H; Wickramanayake, PD; Wolf, J | 1 |
| Byrne, JL; Carter, GI; Cull, GM; Hale, G; Haynes, AP; Miflin, G; Rebello, P; Russell, NH; Waldmann, H | 1 |
| Bode, U; Deckert-Schlüter, M; Fischer, HP; Glasmacher, A; Kleinschmidt, R; Oehring, R; Pels, H; Schlegel, U | 1 |
| Bruty, SJ; Duncombe, AS; George, P; Sweetenham, JW; Wyre, RM | 1 |
| Klener, P; Procházka, B; Slabý, J; Trnený, M | 1 |
| Bamberg, M; Brugger, W; Dichgans, J; Herrlinger, U; Kanz, L; Kortmann, RD; Schabet, M; Weller, M | 1 |
| Chan, JK; Cheung, MM; So, JC; Wong, KF | 1 |
| Biagi, E; Conter, V; Lazzareschi, I; Milani, M; Riccardi, R; Ruggiero, A; Sparano, P | 1 |
| Bernard, M; Haegelen, C; Morandi, X; Riffaud, L | 1 |
| Bode, U; Deckert, M; Fimmers, R; Fliessbach, K; Glasmacher, A; Helmstaedter, C; Kleinschmidt, R; Klockgether, T; Pels, H; Schlegel, U; Schmidt-Wolf, I; Van Roost, D | 1 |
| Ariola, C; Cordone, I; Fazi, F; Fenu, S; Mandelli, F; Montefusco, E; Nanni, M; Petti, MC; Spadea, A; Spiriti, MA | 1 |
| Croockewit, AJ; Fibbe, WE; Kingma, T; Uyl-de Groot, CA; van Agthoven, M; van Imhoff, GW; van Oers, MH; Vellenga, E; Verdonck, LF; Volkers, CP; Wijermans, PJ | 1 |
| Hosomi, Y; Shibuya, M | 1 |
| Bessell, EM; Byrne, P; Graus, F; López-Guillermo, A; Montserrat, E; Nomdedeu, B; Petit, J; Verger, E; Villá, S | 1 |
| Becherer, A; Dudczak, R; Greinix, HT; Jaeger, U; Kalhs, P; Karanikas, G; Kletter, K; Mitterbauer, M; Pötzi, C; Raderer, M | 1 |
| Alessandrino, EP; Arcaini, L; Astori, C; Bernasconi, P; Brusamolino, E; Cairoli, R; Calatroni, S; Colombo, AA; Gargantini, L; Iacona, I; Lazzarino, M; Morra, E; Orlandi, E; Pagnucco, G; Regazzi, MB | 1 |
| Carpenito, G; Kurtz, I | 1 |
| Canellos, GP; Chaffey, JT; Hellman, S; Moloney, WC; Rosenthal, DS; Skarin, AT | 1 |
| Coltman, CA; Jones, SE; Luce, JK; McKelvey, EM; Moon, TE | 1 |
| Ekert, H; Lubitz, L | 1 |
| Koelmel, HW; Weizsaecker, M | 1 |
| Portlock, CS; Rosenberg, SA | 1 |
| Bartolucci, AA; Dorfman, RF; Durant, JR; Gams, RA | 1 |
| Sweet, DL; Ultmann, JE | 1 |
| Bodey, GP; Rodriguez, V | 1 |
| Burchenal, JH; Currie, VE; Krakoff, IH; Mackey, RW; Tan, CT; Wong, PP; Young, CW | 1 |
| Bonmassar, E; Fioretti, MC; Giampietri, A; Goldin, A; Puccetti, P; Riccardi, C | 1 |
| Grünwald, HW; Hirshaut, Y; Rosner, F | 1 |
| Coltman, C; Gamble, JF; Gottlieb, JA; Grozea, PN; Gutterman, J; Haut, A; Jones, SE; Lane, M; McKelvey, EM; Moon, TE; Stephens, R; Talley, RW; Wilson, HE | 1 |
| Kremer, WB | 1 |
| Burchenal, J; D'angio, G; Exelby, P; Fang, S; Lieberman, P; Murphy, ML; Wollner, N | 1 |
| Kaplan, HS; Rosenberg, SA | 1 |
| Chan, YK; Dorfman, R; Durant, JR; Loeb, V | 1 |
| Burchenal, JH; D'Angio, GJ; Exelby, PR; Lieberman, PH; Murphy, ML; Wollner, N | 1 |
| Kernbaum, S | 1 |
| Burchenal, JH; D'Angio, G; Exelby, P; Lieberman, PH; Murphy, ML; Wollner, N | 1 |
| Chabner, BA; Duffey, PL; Longo, DL; Urba, WJ; Wilson, WH; Wittes, R | 1 |
| Ashihara, E; Fujita, N; Goto, H; Inaba, T; Ito, K; Murakami, S; Okawa, K; Oku, N; Shimazaki, C; Tsuji, H | 1 |
| Andrykowski, MA; Brady, MJ; Gregg, ME; Henslee-Downey, PJ; Lamb, DG; Schmitt, FA | 1 |
| Amadori, S; Guglielmi, C; Mandelli, F; Martelli, M; Papa, G | 1 |
| Janmohammed, RM; Leyland, MJ; Long, SG; Macdonald, DF; Milligan, DW; Smith, AG | 1 |
| Chandler, C; Devine, S; Geller, RB; Larson, RA; Myers, S; O'Toole, K; Park, CL; Topper, RL; Williams, SF | 1 |
| Cersosimo, RJ | 1 |
| Brambilla Pisoni, G; Calloni, MV; Montalbetti, L; Trotti, G | 1 |
| Agur, Z; Arnon, R; Schechter, B | 1 |
| Chang, SC; Hsu, JR; Perng, RP | 1 |
| Akerman, S; Chan, K; Dantis, E; DeAngelis, LM; Kreis, W | 1 |
| Bulgarini, B; De Vecchis, L; Giuliani, A; Turriziani, M | 1 |
| Chan, WC; Krendel, DA; Stahl, RL | 1 |
| Crocker, I; Dobbs, CK; Gordon, DS; Heffner, LT; Reynolds, R; Sternberg, P; Vogler, WR; Winton, EF | 1 |
| Carpen, M; Cohen, JS; Daly, PF; Myers, CE; Sandler, D; Zugmaier, G | 1 |
| Chiba, Y; Fujitsu, K; Hayashi, A; Kuwabara, T; Kyuma, Y; Oda, M; Sekido, K; Shinonaga, M; Yamaguchi, K; Yamashita, T | 1 |
| Brandwein, JM; Callum, J; Keating, A; Scott, JG; Sutcliffe, SB | 1 |
| Burns, LJ; Fyfe, MA; Ginder, GD; Gingrich, RD; Wen, BC | 1 |
| Baume, D; Carde, P; Droz, JP; Gilles, E; Hayat, M; Moran, A; Ostronoff, M; Pico, JL; Zambon, E | 1 |
| Barth, RF; Groscurth, P; Hengartner, H; Langhals, H; Schott, H; Schwendener, RA; Trüb, T | 1 |
| Friedenberg, WR; Norfleet, RG; Siemers, RF | 1 |
| Madewell, BR | 1 |
| Bron, D; Stryckmans, P; Vandenheule, B | 1 |
| Archimbaud, E; Berger, F; Bryon, PA; Coiffier, B; Extra, JM; Ffrench, M; Fiere, D; Gentilhomme, O; Guyotat, D; Magaud, JP | 1 |
| Anderson, T; Baumann, MA; Hande, KR; Ritch, PS; Topping, TM; Williams, GA | 1 |
| Borri-Voltattorni, C; Dominici, P; Fioretti, MC; Fuschiotti, P; Puccetti, P; Romani, L | 1 |
| Deyton, L; Gill, PS; Krailo, M; Levine, AM; Loureiro, C; Meyer, P; Rarick, MU; Rasheed, S | 1 |
| Bentley, DP; Campbell, IA; Green, AR; Poynton, C | 1 |
| Bernard, P; Boiron, JM; Marit, G; Reiffers, J; Rice, A; Vezon, G | 1 |
| Haimovich, J; Hurwitz, E | 1 |
| Cuthbert, RJ; Parker, AC; Sheehan, T | 1 |
| Armata, J; Bogusławska-Jaworska, J; Daszkiewicz, P; Dłuzniewska, A; Kazanowska, B; Koehler, M; Matysiak, M; Ochocka, M; Pietras, W; Rodziewicz-Magott, B | 1 |
| Appelbaum, FR; Bigelow, CL; Buckner, CD; Clift, RA; Fefer, A; Petersen, FB; Sanders, JE; Storb, R; Sullivan, KM; Weiden, PL | 1 |
| Dalton, J; Friedman, AH; Strauchen, JA | 1 |
| Kopper, L; Pogany, G; Sasvári-Székely, M; Soóki-Tóth, A; Spasokukotskaja, T; Staub, M | 1 |
| Bankert, RB; Ghosh, SK; Jou, YH; Mayhew, E; Yokota, S | 1 |
| Avramis, VI; Coates, TD; Lenarsky, C; Ozkaynak, MF; Parkman, R; Sato, JK; Weinberg, KI; Willoughby, ML | 1 |
| Cousar, JB; Greco, FA; Greer, JP; Hainsworth, JD; Stein, RS; Wolff, SN | 1 |
| Cabanillas, F; Hagemeister, FB; Jagannath, S; McLaughlin, P; Redman, JR; Rodriguez, MA; Swan, F; Velasquez, WS | 1 |
| Blaise, D; Gaspard, MH; Gastaut, JA; Maraninchi, D; Michel, G; Novakovitch, G; Rossi, JF; Stoppa, AM; Tubiana, N; Weiller, PJ | 1 |
| Esumi, N; Fujiwara, F; Hashida, T; Ikushima, S; Imashuku, S; Ishii, T; Morioka, Y; Okano, S; Todo, S; Yoshihara, T | 1 |
| Giannone, L; Greco, FA; Hainsworth, JD | 1 |
| Bizzi, B; De Stefano, V; Leone, G; Marra, R; Pagano, L | 1 |
| Cabanillas, F; Hagemeister, FB; McLaughlin, P; Redman, JR; Rodriguez, MA; Velasquez, WS; Yung, WK | 1 |
| Hatae, Y; Hatayama, Y; Nakadate, H; Takeda, T | 1 |
| Huijgens, PC; Ossenkoppele, GJ; Reijneke, RM; Thomas, LL; van der Lelie, J; Wijngaarden, MJ | 1 |
| Cheung, NK; Coccia, PF; Gordon, EM; Herzig, RH; Novak, L; Shina, D; Strandjord, SE; Warkintin, PI | 1 |
| Cabanillas, F; Fridrik, M; Hagemeister, FB; Jagannath, S; McLaughlin, P; Redman, JR; Salvador, P; Swan, F; Tucker, S; Velasquez, WS | 1 |
| Bernasconi, C; Brusamolino, E; Canevari, A; Inverardi, D; Lazzarino, M; Morra, E; Orlandi, E; Pagnucco, G | 1 |
| Bennett, CL; Bitran, JD; Kalokhe, U; Karesh, J; Putterman, A; Recant, W; Shapiro, CM | 1 |
| Baer, MR; Flexner, JM; Greer, JP; Hainsworth, JD; Stein, RS; Wolff, SN | 1 |
| Anderson, CC; Cawley, JC; Goldstone, AH; Harper, PG; Jelliffe, AM; Jones, M; Linch, DC; Machin, SJ; McLennan, KA; Souhami, RL | 1 |
| Colly, LP; Peters, WG; Willemze, R | 1 |
| Appelbaum, FR; Buckner, CD | 1 |
| Lampkin, BC; Wong, KY | 1 |
| Armitage, JO; Bierman, PJ; Gingrich, RD; Klassen, LW; Kumar, PP; Smith, DM; Weisenburger, DD | 1 |
| Cassileth, PA; Gale, RP | 1 |
| Adelstein, DJ; Brown, RA; Cassileth, PA; Coccia, PF; Herzig, GP; Herzig, RH; Hines, JD; Lazarus, HM; Strandjord, S; Wolff, SN | 1 |
| Amaki, I; Hattori, K; Hirota, Y; Hoshino, A; Ichimaru, M; Ito, M; Kimura, I; Kimura, K; Maekawa, T; Ohno, R | 1 |
| Bertino, JR; Odujinrin, OO | 1 |
| Doi, S; Hara, J; Ishihara, S; Kawa, K; Tomita, K; Yabuuchi, H; Yumura, K | 1 |
| Abromowitch, M; Dahl, GV; Kalwinsky, DK; Look, AT; Mirro, J; Murphy, SB; Ochs, J; Pui, CH; Rivera, G | 1 |
| Lie, SO; Slørdahl, S | 1 |
| Fujita, N; Haruyama, H; Ijichi, H; Nakagawa, M; Nakanishi, S; Nishio, A; Shimazaki, C | 1 |
| Akashi, M; Furukawa, Y; Ikeda, K; Komatsu, N; Muroi, K; Ohsaka, A; Ohta, M; Suda, K; Takeda, K; Yoshida, M | 1 |
| Ettinger, LJ; Jones, GR | 1 |
| Dabich, L; Ensminger, WD; LoBuglio, AF; Wheeler, RH; Zuckerman, KS | 1 |
| Brambilla, P; Mocarelli, P; Neri, MG; Pessina, A | 1 |
| Gaynor, ER; Golomb, HM; Sweet, DL; Ultmann, JE | 1 |
| Boyett, J; Crist, W; Doering, EJ; Hvizdala, E; Pullen, J; Ruymann, F; Steuber, CP; Sullivan, MP; Trueworthy, R | 1 |
| Seeber, S | 1 |
| Gassmann, W; Löffler, H; Schmitz, N | 1 |
| Cheung, NK; Coccia, PF; Gordon, EM; Graham-Pole, J; Gross, S; Herzig, RH; Lazarus, HM; Spitzer, TR; Strandjord, SE; Warkentin, PI | 1 |
| Coccia, PF; Herzig, GP; Herzig, RH; Lazarus, HM; Wolff, SN | 1 |
| Cazellas, P; David, R; Douay, L; Gorin, NC; Jansen, J; Laporte, JP; Lopez, M; Rio, B; Stachowiak, J; Zittoun, R | 1 |
| Lemerle, J | 1 |
| Inoh, A; Kajitani, T; Kamiya, K; Seyama, T; Yanagihara, K; Yokoro, K | 1 |
| Barnett, MJ; Butler, MG; Ganesan, TS; Lister, TA; Richards, MA; Rohatiner, AZ; Slevin, ML; Smith, BF; Waxman, JH | 1 |
| Arakawa, S; Esumi, N; Imashuku, S; Todo, S | 1 |
| Ito, K; Kobayashi, K; Matsuda, T; Nakagoshi, T; Nakamura, E; Nakamura, S; Nakanishi, J; Natori, K; Ohtake, S; Yoshida, T | 1 |
| Anderson, T; Frick, JC; Hansen, RM; Ritch, PS | 1 |
| Cohen, A; Ullman, B | 1 |
| Amadori, S; Anselmo, AP; Biagini, C; Cimino, G; Guglielmi, C; Mandelli, F; Papa, G; Ruco, LP | 1 |
| Barnett, MJ; Dhaliwal, HS; Gallagher, CJ; Lister, TA; Richards, MA; Rohatiner, AZ; Waxman, JH | 1 |
| Adelstein, DJ; Herzig, RH; Hines, JD; Lazarus, HM | 1 |
| Anderson, J; Green, MR; Schilsky, RL | 1 |
| Glynn, JP; Goldberg, AI; Goldin, A; Kende, M; Mantel, N | 1 |
| Fortuny, IE; Kennedy, BJ; Theologides, A; Weiss, R | 1 |
| Ablashi, DV; Dienhardt, F; Falk, L; Klein, G; Pearson, G; Rabin, H; Rabson, A; Wolfe, L | 1 |
| Hays, EF | 1 |
| Ablashi, DV; Adamson, RH; Cicmanec, JL; Dalgard, DW | 1 |
| Sambrook, J; Shatkin, AJ | 1 |
| Bergsagel, DE | 1 |
| Schabel, FM; Skipper, HE | 1 |
| Jordan, GW; Merigan, TC; Stevens, DA; Waddell, TF | 1 |
| Karran, P | 1 |
| Fortner, CL; Greene, WH; Schimpff, SC; Wiernik, PH | 1 |
| Davies, DA | 1 |
| Benoy, CJ; Elson, LA; Jones, M; Schneider, R | 1 |
| Cheeks, JB; Laster, WR; Schabel, FM; Skipper, HE; Trader, MW | 1 |
| Dedrick, RL; Forrester, DD; Ho, DH | 1 |
| Frei, E; Goldin, A; Schabel, FM | 1 |
| Canellos, GP; O'Connell, M; Rosenoff, SH; Wiernik, PH | 1 |
| Bax, I; Greenberg, P; Mara, B; Schrier, S | 1 |
| Crowther, D | 1 |
| Bodey, GP; Freireich, EJ; Rodriguez, V | 1 |
| Carter, SK | 1 |
| Berchenal, J | 1 |
| Knospe, WH | 1 |
| Gutterman, JU; Hersh, EM; Mavligit, GM; Reed, RC | 1 |
| Barranco, SC; Drewinko, B; Ho, DH | 1 |
| Cikes, M; Klein, G | 1 |
| Beyer, R; Forster, W; Maidhof, A; Müller, WE; Zahn, RK | 1 |
| Frei, E; Gottlieb, JA; Gutterman, JU; McCredie, KB; Rodriguez, V | 1 |
| Tungsubutra, K | 1 |
| Harrap, KR; Tattersall, MH | 1 |
| Nixon, DD; Ultmann, JE | 1 |
| Morrone, G | 1 |
| Fairley, GH | 1 |
| Ota, K | 1 |
| Benoy, CJ; Elson, LA; Schneider, R | 1 |
| Müller, WE; Sögtrop, HH; Yamazaki, ZI; Zahn, RK | 1 |
| White, LP | 1 |
| Laster, WR; Schabel, FM; Skipper, HE; Trader, MW | 1 |
| Bruce, DL; Bruce, WR; Lin, HS | 1 |
| Bruce, WR; Meeker, BE; Powers, WE; Valeriote, FA | 1 |
| Burns, SL; Savel, H | 1 |
33 review(s) available for cytarabine and Lymphoma
| Article | Year |
|---|---|
[Chemotherapy using gemcitabine hydrochloride for malignant lymphoma].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Deoxycytidine; Gemcitabine; Humans; Lymphoma; Practice Guidelines as Topic | 2013 |
The role of additional radiotherapy for primary central nervous system lymphoma.
Topics: Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Early Termination of Clinical Trials; Humans; Lymphoma; Methotrexate; Randomized Controlled Trials as Topic | 2014 |
Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine.
Topics: Antimetabolites, Antineoplastic; Capsules; Clinical Trials as Topic; Cytarabine; Humans; Injections, Spinal; Leukemia; Liposomes; Lymphoma; Meningitis; Treatment Outcome | 2008 |
Primary central nervous system lymphoma: recent progress, many remaining questions.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Methotrexate; Rituximab | 2009 |
Treatment approaches for primary CNS lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cytarabine; Dose-Response Relationship, Drug; Humans; Lymphoma; Methotrexate; Prognosis; Radiotherapy; Randomized Controlled Trials as Topic; Stem Cell Transplantation | 2010 |
[Malignant lymphoma: individualized treatment according to biological and clinical risk factors].
Topics: Age Factors; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Boronic Acids; Bortezomib; Clinical Trials as Topic; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Ki-1 Antigen; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Precision Medicine; Prognosis; Pyrazines; Risk Factors; Rituximab; Survival Rate; Waldenstrom Macroglobulinemia | 2011 |
Management of leptomeningeal malignancy.
Topics: Adenocarcinoma; Algorithms; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Arachnoid Cysts; Carcinoma; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Delayed-Action Preparations; Enzyme Inhibitors; Humans; Injections, Intravenous; Injections, Spinal; Leukemia; Lymphoma; Meningeal Neoplasms; Methotrexate; Palliative Care; Randomized Controlled Trials as Topic; Thiotepa; Topoisomerase I Inhibitors; Topotecan | 2005 |
Secondary central nervous system lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Cytarabine; Female; Humans; Lymphoma; Male; Recurrence; Rituximab; Stem Cell Transplantation | 2006 |
Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments.
Topics: Animals; Cytarabine; Humans; Leukemia; Liposomes; Lymphoma; Meningitis; Randomized Controlled Trials as Topic | 2008 |
[Neurological problems in malignant hemopathies in children. II. Neurotoxicity of antiblastic drugs and radiotherapy].
Topics: Antineoplastic Agents; Asparaginase; Central Nervous System Diseases; Child; Child, Preschool; Cytarabine; Humans; Infant; Leukemia; Lymphoma; Methotrexate; Radiotherapy; Vincristine | 1982 |
[High dose chemotherapy followed by hematopoietic stem cell transplantation for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Salvage Therapy; Vinblastine; Vincristine | 1995 |
Intrathecal chemotherapy with antineoplastic agents in children.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Blood-Brain Barrier; Cerebellar Neoplasms; Cerebrospinal Fluid; Child; Cytarabine; Humans; Injections, Spinal; Lymphoma; Medulloblastoma; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thiotepa | 2001 |
[Combination chemotherapy with VP-16 in the treatment of lung cancer and malignant lymphoma].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase II as Topic; Cytarabine; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Lymphoma; Mesna; Methylprednisolone; Mitoxantrone | 2001 |
The place of radiation therapy in the treatment of non-Hodgkin's lymphomas.
Topics: Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymph Nodes; Lymphoma; Male; Methotrexate; Prednisone; Remission, Spontaneous; Time Factors; Vincristine | 1977 |
Chemotherapy of non-Hodgkin lymphoma: the diffuse types.
Topics: Antineoplastic Agents; Central Nervous System Diseases; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Leucovorin; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasms; Prednisone; Remission, Spontaneous; Vincristine | 1978 |
Approaches to the treatment of acute leukemia and lymphoma in adults.
Topics: Acute Disease; Adult; Animals; BCG Vaccine; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Environment, Controlled; Humans; Immunotherapy; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Mice; Prednisone; Vincristine | 1978 |
Recent National Cancer Institute lymphoma trials of etoposide-containing combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma; Methotrexate; National Institutes of Health (U.S.); Prednisone; United States; Vincristine | 1992 |
Idarubicin: an anthracycline antineoplastic agent.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Breast Neoplasms; Cytarabine; Drug Labeling; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1992 |
Canine lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cyclophosphamide; Cytarabine; Dog Diseases; Dogs; Drug Combinations; Lymph Nodes; Lymphoma; Palliative Care; Prednisone; Vincristine | 1985 |
[Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Vincristine | 1985 |
Overview of the clinical relevance of autologous bone marrow transplantation.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Evaluation; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Melphalan; Neoplasm Recurrence, Local; Neoplasms; Thioguanine; Transplantation, Autologous | 1986 |
Indications for and benefits of intensive therapies in treatment of childhood cancers.
Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Etoposide; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Melphalan; Methotrexate; Neoplasms; Osteosarcoma; Risk; Sarcoma, Ewing | 1986 |
Amsacrine: a review.
Topics: Amsacrine; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Evaluation; Drug Resistance; Humans; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma | 1986 |
An assessment of massive-dose chemotherapy of malignant disease.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Cell Division; Cyclophosphamide; Cytarabine; Female; Fluorouracil; Humans; Leukemia L1210; Leukemia, Lymphoid; Lymphoma; Melphalan; Mercaptopurine; Methotrexate; Mice; Multiple Myeloma; Neoplasms; Nitrogen Mustard Compounds; Prednisone; Pregnancy; Time Factors; Trophoblastic Neoplasms; Vinblastine | 1971 |
Combination chemotherapy for lymphomas and leukemias.
Topics: Adult; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Combinations; Hodgkin Disease; Humans; Immunotherapy; Infections; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Mercaptopurine; Methotrexate; Middle Aged; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous; Vincristine | 1973 |
An overview of the status of the nitrosoureas in other tumors.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Hodgkin Disease; Humans; Hydroxyurea; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Melanoma; Melphalan; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Vincristine | 1973 |
[Achievements in the treatment of leukemia and lymphoma].
Topics: Acute Disease; Animals; Antineoplastic Agents; Burkitt Lymphoma; Chemical Phenomena; Chemistry; Cytarabine; Drug Therapy, Combination; Humans; Immunotherapy; Leukemia; Lymphoma; Methods; Remission, Spontaneous; Time Factors | 1973 |
Malignant lymphoma. 2. Therapy.
Topics: Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Vincristine | 1974 |
Immunochemotherapy of human cancer.
Topics: Acute Disease; Adjuvants, Immunologic; Adult; Animals; Antineoplastic Agents; BCG Vaccine; Cytarabine; Humans; Immunosuppressive Agents; Immunotherapy; Leukemia L1210; Lymphoma; Melanoma; Mice; Neoplasms; Neoplasms, Experimental; Prednisone; Vincristine | 1974 |
The therapy of lymphoma.
Topics: Adrenal Cortex Hormones; Asparaginase; Bone Marrow Diseases; Chlorambucil; Cyclophosphamide; Cytarabine; Daunorubicin; Fever; Humans; Hydrazines; Infections; Kidney Failure, Chronic; Lymphoma; Mechlorethamine; Splenectomy; Vinblastine; Vincristine | 1969 |
[Cytostatic chemotherapy of neoplasms in children].
Topics: Adrenal Cortex Hormones; Aminopterin; Antineoplastic Agents; Asparaginase; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Cytarabine; Daunorubicin; Fluorouracil; Humans; Leukemia; Lymphoma; Mercaptopurine; Methotrexate; Nitrogen Mustard Compounds; Procarbazine; Sarcoma; Vinblastine; Vincristine | 1971 |
Combination chemotherapy in malignant diseases.
Topics: Adult; Antineoplastic Agents; Asparaginase; Carmustine; Child; Cyclophosphamide; Cytarabine; Cytosine; Daunorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Immunotherapy; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Mechlorethamine; Mercaptopurine; Methotrexate; Nitrogen Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Remission, Spontaneous; Vincristine | 1971 |
Multiple combination therapy in cancer chemotherapy in Japan.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Chloroquine; Cyclophosphamide; Cytarabine; Drug Synergism; Fluorouracil; Humans; Japan; Leukemia; Lymphoma; Mercaptopurine; Mitomycins; Neoplasms; Podophyllin; Prednisolone; Thiotepa; Vincristine; Vitamin K 1 | 1969 |
96 trial(s) available for cytarabine and Lymphoma
| Article | Year |
|---|---|
Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Decitabine; Humans; Leukemia, Myeloid, Acute; Lymphoma; Vorinostat | 2022 |
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Methotrexate; Quality of Life; Rituximab; Thiotepa; Transplantation, Autologous | 2022 |
Multidrug chemotherapy, whole-brain radiation and cytarabine therapy for primary central nervous system lymphoma in elderly patients with dose modification based on geriatric assessment: study protocol for a phase II, multicentre, non-randomised study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System; Central Nervous System Neoplasms; Clinical Trials, Phase II as Topic; Cytarabine; Humans; Lymphoma; Methotrexate; Multicenter Studies as Topic; Prospective Studies; Rituximab; Treatment Outcome; Vincristine | 2023 |
Impact of the Conditioning Regimen Dose Intensity Before Autologous Stem Cell Transplantation on the Pulmonary Function Test Abnormalities in Patients With Lymphoma and Multiple Myeloma: Single Center Experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Carmustine; Cytarabine; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Podophyllotoxin; Respiratory Function Tests; Retrospective Studies; Survival Rate; Transplantation Conditioning | 2020 |
Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Injections, Intraventricular; Karnofsky Performance Status; Lymphoma; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Pilot Projects; Survival Analysis | 2020 |
Impact of contemporary regimens on the outcomes and toxicity of primary CNS lymphoma: a single-center retrospective analysis of 73 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rituximab; Survival Rate; Venous Thromboembolism | 2021 |
MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy, Adjuvant; Cytarabine; Disease-Free Survival; Female; Humans; Lymphoma; Male; Mental Status and Dementia Tests; Methotrexate; Middle Aged; Neurosurgical Procedures; Prognosis; Risk Factors; Rituximab | 2021 |
Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 years.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Etoposide; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy | 2022 |
A single institutional retrospective evaluation for younger patients with primary central nervous lymphomas on a modified R-MPV regimen followed by radiotherapy and high dose cytarabine.
Topics: Aftercare; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Cytarabine; Disease-Free Survival; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Procarbazine; Rituximab; Survival Rate | 2017 |
Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Central Nervous System Neoplasms; Cytarabine; Dexamethasone; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Proto-Oncogene Proteins c-bcl-6; Teniposide; Treatment Outcome; Young Adult | 2018 |
Outcomes of Patients with Recurrent and Refractory Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation with BEAM Conditioning and Sirolimus- and Tacrolimus-Based GVHD Prophylaxis.
Topics: Adolescent; Adult; Allografts; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Lymphoma; Male; Melphalan; Middle Aged; Podophyllotoxin; Sirolimus; Survival Rate; Tacrolimus; Transplantation Conditioning | 2019 |
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Cranial Irradiation; Cytarabine; Disease-Free Survival; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Procarbazine; Rituximab; Time; Treatment Outcome; Vincristine | 2013 |
The efficacy and adverse event profile of dexamethasone, melphalan, actinomycin D, and cytosine arabinoside (DMAC) chemotherapy in relapsed canine lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dactinomycin; Dexamethasone; Dog Diseases; Dogs; Female; Lymphoma; Male; Melphalan; Recurrence; Retrospective Studies | 2014 |
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Deoxycytidine; Dexamethasone; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Quality of Life; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2014 |
Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dacarbazine; Disease-Free Survival; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Procarbazine; Prospective Studies; Quality of Life; Temozolomide; Treatment Outcome; Vincristine | 2015 |
Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes.
Topics: Adult; Aged; Busulfan; Carmustine; Cyclophosphamide; Cytarabine; Drug Combinations; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Middle Aged; North America; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous | 2016 |
A randomized, double-blind trial of pegfilgrastim versus filgrastim for the management of neutropenia during CHASE(R) chemotherapy for malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Management; Double-Blind Method; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Rituximab; Young Adult | 2016 |
Primary Oculocerebral Lymphoma: MTX Polychemotherapy Alone on Intraocular Disease Control.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cerebellum; Cytarabine; Dacarbazine; Eye Neoplasms; Female; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Procarbazine; Survival Analysis; Temozolomide; Vincristine | 2016 |
Phase II Study of Propylene Glycol-Free Melphalan Combined with Carmustine, Etoposide, and Cytarabine for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
Topics: Adolescent; Adult; Aged; Carmustine; Cytarabine; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Myeloablative Agonists; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult | 2016 |
Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial.
Topics: Adult; Age Factors; Aged; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Stem Cell Transplantation; Treatment Outcome | 2017 |
BEAM conditioning is well-tolerated and yields similar survival in obese and non-obese patients with lymphoma: no requirement for weight-based dose modifications.
Topics: Adult; Aged; Allografts; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Obesity; Podophyllotoxin; Prospective Studies; Transplantation Conditioning | 2017 |
Treatment of oral mucositis after peripheral blood SCT with ATL-104 mouthwash: results from a randomized, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Double-Blind Method; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Mouthwashes; Phytohemagglutinins; Pilot Projects; Placebos; Recombinant Proteins; Stomatitis | 2009 |
Liposomal cytarabine in advanced-stage acute lymphoblastic leukemia and aggressive lymphoma with central nervous system involvement: experience of the Polish Acute Leukemia Group.
Topics: Adolescent; Adult; Aged; Central Nervous System Neoplasms; Cytarabine; Drug Carriers; Female; Humans; Liposomes; Lymphoma; Male; Middle Aged; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Treatment Outcome; Young Adult | 2009 |
Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Feasibility Studies; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Kinetics; Lymphoma; Male; Melphalan; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult | 2010 |
Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Societies, Medical; Time Factors; Vincristine; Young Adult | 2010 |
Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial.
Topics: Antimetabolites, Antineoplastic; Area Under Curve; Central Nervous System Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; International Cooperation; Lymphoma; Male; Methotrexate; Middle Aged; Prognosis; Survival Analysis; Treatment Outcome | 2010 |
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chi-Square Distribution; Cranial Irradiation; Cytarabine; Disease-Free Survival; Dose Fractionation, Radiation; Female; Germany; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Radiotherapy, Adjuvant; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Treatment Outcome | 2010 |
A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection.
Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Carmustine; Combined Modality Therapy; Cytarabine; Cytoprotection; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lymphoma; Male; Maximum Tolerated Dose; Melphalan; Middle Aged; Mucositis; Pancytopenia; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Transplantation Conditioning; Transplantation, Autologous; Young Adult | 2011 |
Methotrexate- and/or cytarabine-based chemotherapy may be effective and safe in solid-organ transplant recipients with primary central nervous system lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Feasibility Studies; Follow-Up Studies; Humans; Immunosuppression Therapy; Lymphoma; Methotrexate; Middle Aged; Organ Transplantation; Recurrence; Remission Induction; Transplantation; Treatment Outcome | 2011 |
Clinical relevance of the dose of cytarabine in the upfront treatment of primary CNS lymphomas with methotrexate-cytarabine combination.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Pilot Projects; Salvage Therapy; Survival Rate; Thiotepa | 2011 |
Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Consolidation Chemotherapy; Cytarabine; Dacarbazine; Diffusion Magnetic Resonance Imaging; Etoposide; Female; Humans; Immunotherapy; Lymphoma; Male; Methotrexate; Middle Aged; Prognosis; Remission Induction; Rituximab; Survival Analysis; Temozolomide; Treatment Outcome | 2012 |
Allogeneic stem cell transplantation for relapsed or refractory lymphoma after conditioning with BEAM/fludarabine/TBI.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Melphalan; Middle Aged; Myeloablative Agonists; Podophyllotoxin; Recurrence; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2013 |
Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Autografts; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Multiple Myeloma; Neutropenia; Platelet Transfusion; Time Factors | 2013 |
[Mobilization of autologous peripheral blood stem cells by cytosine arabinoside combined with recombinant human granulocyte colony-stimulating factor].
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Cell Movement; Child; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Lymphoma; Male; Middle Aged; Recombinant Proteins | 2002 |
High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.
Topics: Adolescent; Adult; Antigens, CD34; Antimetabolites, Antineoplastic; Blood Cell Count; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Graft Survival; Hematopoiesis; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma; Middle Aged; Peripheral Blood Stem Cell Transplantation; Risk; Transplantation, Autologous | 2002 |
Pilot phase I/II study of new salvage therapy (CHASE) for refractory or relapsed malignant lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Remission Induction; Salvage Therapy; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2003 |
Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Belgium; Biopsy, Needle; Central Nervous System Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Spinal; Lomustine; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Multivariate Analysis; Neoplasm Staging; Probability; Procarbazine; Research; Risk Assessment; Survival Analysis; Treatment Outcome | 2003 |
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Bromodeoxyuridine; Central Nervous System Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Infusions, Intravenous; Lymphoma; Male; Methotrexate; Middle Aged; Treatment Outcome | 2003 |
Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Female; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Middle Aged; Pilot Projects; Prednisolone; Survival Analysis; Treatment Outcome | 2003 |
The development of targeted chemotherapy for CNS lymphoma-a pilot study of the IDARAM regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Idarubicin; Lymphoma; Male; Methotrexate; Middle Aged; Pilot Projects; United Kingdom | 2004 |
Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Female; Humans; Lymphoma; Male; Melphalan; Methotrexate; Middle Aged; Prednisone; Remission Induction; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Vincristine; Vindesine | 2004 |
Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: a single-centre sequential-cohort study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cohort Studies; Cytarabine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Male; Melphalan; Middle Aged; Multivariate Analysis; Retrospective Studies; Time Factors; Transplantation Conditioning; Transplantation, Autologous | 2004 |
Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cell Culture Techniques; Cells, Cultured; Cyclophosphamide; Cytarabine; Erythroid Precursor Cells; Humans; Integrin beta3; Lymphoma; Megakaryocytes; Melphalan; Peripheral Blood Stem Cell Transplantation; Platelet Membrane Glycoprotein IIb; Platelet Transfusion; Salvage Therapy; Thrombocytopenia; Thrombopoietin; Transplantation, Autologous; Treatment Outcome | 2004 |
Glomerular dysfunction, independent of tubular dysfunction, induced by antineoplastic chemotherapy in children.
Topics: Acute Disease; Adolescent; Albuminuria; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Creatinine; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Glomerular Filtration Rate; Humans; Kidney Tubules; Leukemia; Lymphoma; Methotrexate; Neoplasms; Neuroblastoma; Osteosarcoma; Proteinuria; Rhabdomyosarcoma; Vincristine | 2004 |
Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary report.
Topics: Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Cytoprotection; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Middle Aged; Radiation-Protective Agents; Transplantation, Autologous | 2004 |
First-line autologous stem cell transplantation in primary CNS lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompetence; Lymphoma; Male; Melphalan; Middle Aged; Neurotoxicity Syndromes; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Survival Rate; Transplantation, Autologous | 2005 |
High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Cranial Irradiation; Cytarabine; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Germany; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Radiotherapy, Adjuvant; Thiotepa; Transplantation, Autologous; Treatment Outcome | 2006 |
Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Polyethylene Glycols; Recombinant Proteins; Remission Induction; Transplantation, Autologous; Treatment Outcome | 2006 |
A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Cytarabine; Delayed-Action Preparations; Disease Progression; Female; Humans; Injections, Spinal; Leukemia; Lymphoma; Male; Meningeal Neoplasms; Meningitis; Middle Aged | 2007 |
High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Remission Induction; Stem Cell Transplantation; Transplantation, Autologous | 2006 |
Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Paclitaxel; Recurrence; Stem Cells; Time Factors; Vinblastine; Vinorelbine | 2006 |
Topotecan, Ara-C, cisplatin and prednisolone (Toposhap) for patients with refractory and relapsing lymphomas: Results of a phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Recurrence; Salvage Therapy; Survival Analysis; Topotecan | 2006 |
Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gastrointestinal Diseases; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Salvage Therapy; Sepsis; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2007 |
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Lymphoma; Male; Melphalan; Remission Induction; Transplantation Conditioning; Transplantation, Homologous | 2007 |
Marked elevation in homocysteine and homocysteine sulfinic acid in the cerebrospinal fluid of lymphoma patients receiving intensive treatment with methotrexate.
Topics: Adult; Aged; Alleles; Antimetabolites, Antineoplastic; Brain Chemistry; Central Nervous System Neoplasms; Cytarabine; Excitatory Amino Acids; Female; Homocysteine; Humans; Injections, Intravenous; Injections, Intraventricular; Lymphoma; Male; Methotrexate; Middle Aged; Neurotoxicity Syndromes; Pilot Projects; S-Adenosylmethionine; Statistics, Nonparametric; Time Factors | 2007 |
[The so-called partial synchronization in the treatment of malignant lymphomas. A clinical study].
Topics: Bleomycin; Cell Division; Clinical Trials as Topic; Cytarabine; Doxorubicin; Fluorouracil; Hodgkin Disease; Humans; Hydroxyurea; Lymphoma; Neoplasm Invasiveness; Remission, Spontaneous; Vinca Alkaloids | 1980 |
[New agents in the treatment of leukemia and lymphoma].
Topics: Aclarubicin; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Clinical Trials as Topic; Cytarabine; Doxorubicin; Drug Evaluation; Humans; Infusions, Parenteral; Leukemia, Myeloid, Acute; Lymphoma; Middle Aged; Naphthacenes | 1983 |
Sequential combination of systemic high-dose ara-C and asparaginase for the treatment of central nervous system leukemia and lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child; Clinical Trials as Topic; Cytarabine; Humans; Leukemia; Lymphoma; Male; Meningeal Neoplasms; Tomography, X-Ray Computed | 1984 |
NHL-3 protocol. Six-drug combination chemotherapy for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Leukocyte Count; Lymphoma; Male; Methotrexate; Middle Aged; Platelet Count; Prednisone; Vincristine | 1984 |
Prolonged daily administration of oral etoposide in lymphoma following prior therapy with adriamycin, an ifosfamide-containing salvage combination, and intravenous etoposide.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Infusions, Intravenous; Leukopenia; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Palliative Care; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia | 1995 |
[Lymphatic interventional radiology in the treatment of lymphatic neoplasmas].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Lymphatic Metastasis; Lymphography; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Radiography, Interventional; Stomach Neoplasms; Thiotepa | 1995 |
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Mesna; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Prednisone; Salvage Therapy | 1994 |
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methylprednisolone; Middle Aged; Prognosis; Recurrence; Remission Induction; Survival Rate | 1994 |
The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Humans; Infant; Leukocyte Count; Lymphoma; Mediastinal Neoplasms; Meningeal Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Survival Rate; Thioguanine; Vincristine | 1993 |
[Study on the inhibitory effect of oral granisetron against nausea/vomiting induced by cytosine arabinoside containing chemotherapy for tumors in the hematopoietic organs].
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Granisetron; Humans; Indazoles; Lymphoma; Male; Middle Aged; Mitoxantrone; Nausea; Vomiting | 1993 |
A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Mesna; Middle Aged; Mitoxantrone; Platinum; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Treatment Failure | 1995 |
Dose intensification of etoposide in the BEAM ABMT protocol for malignant lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Male; Melphalan; Middle Aged | 1995 |
Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Eye Neoplasms; Female; Follow-Up Studies; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Procarbazine; Thiotepa; Tomography, X-Ray Computed; Vincristine | 1996 |
Peripheral blood progenitor cell mobilization with Dexa-Beam/G-CSF, ether lipid purging, and autologous transplantation after high-dose CBV treatment: a safe and effective regimen in patients with poor risk malignant lymphomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Cell Movement; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukapheresis; Lymphoma; Melphalan; Middle Aged; Phospholipid Ethers; Risk Factors; Transplantation Conditioning | 1996 |
Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Cytarabine; Delayed-Action Preparations; Female; Humans; Injections, Spinal; Lymphoma; Male; Meningitis, Aseptic; Middle Aged; Quality of Life; Survival Analysis; Treatment Outcome | 1999 |
ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(-2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Matched-Pair Analysis; Methylprednisolone | 2000 |
Dexamethasone, carmustine, etoposide, cytarabine, and melphalan (dexa-BEAM) followed by high-dose chemotherapy and stem cell rescue--a highly effective regimen for patients with refractory or relapsed indolent lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous | 2000 |
Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Indoles; Lymphoma; Male; Melphalan; Nausea; Ondansetron; Serotonin Antagonists; Transplantation, Autologous; Tropisetron; Vomiting | 2000 |
Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chi-Square Distribution; Cisplatin; Cost-Benefit Analysis; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prospective Studies; Quality of Life; Recurrence; Statistics, Nonparametric; Survival Rate; Transplantation, Autologous | 2001 |
Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Diseases; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Radiotherapy Dosage; Spain; Survival Rate; United Kingdom; Vincristine | 2002 |
Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group.
Topics: Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Time Factors; Vincristine | 1977 |
Chemotherapy of the non-Hodgkin's lymphomas: the Stanford experience.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lymphoma; Male; Middle Aged; Prednisone; Prognosis; Prospective Studies; Thioguanine; Time Factors; Vincristine | 1977 |
BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
Topics: Carmustine; Cell Cycle; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Prognosis; Remission, Spontaneous; Thioguanine; Time Factors; Vincristine | 1977 |
Phase I evaluation of tetrahydrouridine combined with cytosine arabinoside.
Topics: Bone Marrow; Clinical Trials as Topic; Cytarabine; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Humans; Leukemia; Lymphoma; Middle Aged; Neoplasms; Nucleoside Deaminases; Pyrimidine Nucleosides; Tetrahydrouridine; Uridine | 1979 |
Clinical trials in the non-Hodgkin's lymphomata at Stanford University experimental design and preliminary results.
Topics: Antineoplastic Agents; Bone Marrow; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Follow-Up Studies; Humans; Lymph Nodes; Lymphoma; Prognosis; Thioguanine | 1975 |
F-MACHOP in advanced aggressive lymphoma.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Fluorouracil; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine | 1992 |
BEAM autografting in lymphoma--experience at one centre.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Lymphoma; Male; Melphalan; Middle Aged; Survival Rate; Transplantation, Autologous | 1992 |
Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Graft vs Host Disease; Humans; Leukemia; Lymphoma; Male; Middle Aged | 1992 |
High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Clinical Trials as Topic; Combined Modality Therapy; Cytarabine; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Whole-Body Irradiation | 1989 |
[Urotoxicity of enocitabine (BH-AC) and aclarubicin (ACM) in pediatric patients with hematological malignancies].
Topics: Aclarubicin; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Female; Hematuria; Humans; Infant; Leukemia; Lymphoma; Male; Multicenter Studies as Topic; Retrospective Studies | 1988 |
Combination intraventricular chemotherapy for meningeal neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cytarabine; Female; Follow-Up Studies; Humans; Injections, Intraventricular; Lung Neoplasms; Lymphoma; Melanoma; Meningeal Neoplasms; Methotrexate; Thiotepa; Urinary Bladder Neoplasms | 1986 |
Antithrombin III during high-dose cytosine arabinoside therapy with or without asparaginase.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Asparaginase; Cytarabine; Female; Humans; Leukemia; Liver; Lymphoma; Male; Middle Aged | 1986 |
Results of induction and consolidation treatment with intermediate and high-dose ara-C and m-AMSA containing regimens in patients with primarily failed or relapsed acute leukemia and non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aminoacridines; Amsacrine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Daunorubicin; Follow-Up Studies; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Middle Aged | 1986 |
Overview of the clinical relevance of autologous bone marrow transplantation.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Evaluation; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Melphalan; Neoplasm Recurrence, Local; Neoplasms; Thioguanine; Transplantation, Autologous | 1986 |
Trial of high-dose cytarabine, cyclophosphamide, total-body irradiation, and autologous marrow transplantation for refractory lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Pneumonia; Sepsis; Transfusion Reaction; Whole-Body Irradiation | 1986 |
Amsacrine: a review.
Topics: Amsacrine; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Evaluation; Drug Resistance; Humans; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma | 1986 |
Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Marrow; Carmustine; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Meningeal Neoplasms; Methotrexate; Neoplasm Staging; Prednisone; Prognosis; Radiotherapy Dosage; Thioguanine; Vincristine | 1985 |
Treatment of B-cell non-Hodgkin's malignant lymphomas of childhood in Europe: recent and on-going studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Child; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Lymphoma; Methotrexate; Neoplasm Staging; Prednisone; Vincristine | 1985 |
Central nervous system toxicity of high-dose cytosine arabinoside.
Topics: Adolescent; Adult; Aged; Central Nervous System Diseases; Cerebellar Diseases; Clinical Trials as Topic; Cytarabine; Dose-Response Relationship, Drug; Drug Evaluation; Epilepsy, Tonic-Clonic; Female; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Nystagmus, Pathologic; Syndrome; Tremor | 1985 |
Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial.
Topics: Antibody Formation; Blood Cell Count; Clinical Trials as Topic; Complement Fixation Tests; Cytarabine; Herpes Zoster; Herpesvirus 3, Human; Hodgkin Disease; Humans; Infusions, Parenteral; Interferons; Lymphoma; Placebos; Time Factors | 1973 |
Cytosine arabinoside for localized herpes zoster in patients with cancer: failure in a controlled trial.
Topics: Clinical Trials as Topic; Cytarabine; Herpes Zoster; Herpesvirus 3, Human; Hodgkin Disease; Humans; Infusions, Parenteral; Lymphoma; Neoplasms; Placebos | 1974 |
323 other study(ies) available for cytarabine and Lymphoma
| Article | Year |
|---|---|
Guanosine diphosphate-L-fucose plasma: N-acetylglucosaminide fucosyltransferase as in index of bone marrow hyperplasia after chemotherapy.
Topics: Antineoplastic Agents; Bone Marrow; Guanosine Diphosphate Fucose; Hexosyltransferases; Humans; Hyperplasia; Leukemia, Myeloid, Acute; Lymphoma; Remission, Spontaneous | 1978 |
High D-index during mobilization predicts poor mobilization of CD34+ cells after anti-lymphoma salvage chemotherapy.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Cisplatin; Cytarabine; Etoposide; Female; Humans; Lymphoma; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Salvage Therapy; Severity of Illness Index; Young Adult | 2022 |
Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Humans; Lymphoma; Outpatients; Oxaliplatin; Rituximab | 2022 |
Neutrophil decline rate following autologous transplant for lymphoma is a predictor of patients' outcome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autografts; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Neoplasm Recurrence, Local; Neutrophils; Prospective Studies; Transplantation Conditioning; Transplantation, Autologous | 2022 |
Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Retrospective Studies; Semustine; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous | 2022 |
Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cytarabine; Humans; Lomustine; Lymphoma; Methotrexate; Middle Aged; Procarbazine; Receptors, Thrombopoietin; Rituximab | 2022 |
Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; COVID-19; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; In Situ Hybridization, Fluorescence; Lymphoma; Lymphoma, B-Cell; Prednisone; Retrospective Studies; Rituximab; Transplantation, Autologous; Vincristine | 2022 |
Consolidation regimens in primary central nervous system lymphoma: a single-center retrospective cohort evaluating survival outcomes and cost-benefit analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cost-Benefit Analysis; Cytarabine; Humans; Lymphoma; Methotrexate; Retrospective Studies | 2022 |
Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Carmustine; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Retrospective Studies; Transplantation, Autologous | 2023 |
Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cytarabine; Humans; Lymphoma; Methotrexate; Rituximab; Thiotepa | 2023 |
Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cost-Benefit Analysis; Cytarabine; Humans; Lymphoma; Methotrexate; Retrospective Studies; Rituximab; Treatment Outcome | 2022 |
Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous | 2023 |
Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine (R-MIV) in patients with primary CNS lymphoma including recent COVID-19 pandemic experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; COVID-19; Cytarabine; Humans; Ifosfamide; Lymphoma; Methotrexate; Pandemics; Prospective Studies; Rituximab; SARS-CoV-2; Vincristine | 2023 |
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cytarabine; Humans; Lymphoma; Methotrexate; Middle Aged; Retrospective Studies; Rituximab; Temozolomide | 2023 |
Long-Term Results with Thiotepa-Containing Conditioning Regimens for Autologous Stem Cell Transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Retrospective Studies; Thiotepa; Transplantation, Autologous | 2023 |
Treatment of new-onset primary central nervous system lymphoma in elderly patients using RMPV chemotherapy: a single-institution experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cytarabine; Humans; Lymphoma; Methotrexate; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2023 |
The nutritional impact of CD19-targeted CAR-T therapy versus BEAM chemotherapy for adult patients with lymphoma.
Topics: Adult; Antigens, CD19; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Humans; Immunotherapy, Adoptive; Lymphoma; Mucositis; Nausea; Neoplasm Recurrence, Local; Receptors, Chimeric Antigen; Vomiting; Weight Loss | 2023 |
The impact of overweight on renal toxicity in patients treated with dexamethasone, high-dose cytarabine, and cisplatin.
Topics: Antineoplastic Agents; Cisplatin; Cytarabine; Dexamethasone; Female; Humans; Kidney Tubules; Lymphoma; Male; Overweight; Retrospective Studies; Risk Factors; Salvage Therapy | 2020 |
Sodium N-lauryl amino acids derived from silk protein can form catanionic aggregates with cytarabine as novel anti-tumor drug delivery systems.
Topics: Amino Acids; Antimetabolites, Antineoplastic; Cations; Cell Line, Tumor; Cytarabine; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Lymphoma; Sericins; Silk; Surface-Active Agents | 2020 |
BEAM conditioning regimen ensures better progression-free survival compared with TEAM but not with FEAM in lymphoma patients undergoing autologous stem cell transplant.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Progression-Free Survival; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous | 2020 |
A comparison of bendamustine-EAM versus BEAM conditioning for autogolous stem cell transplant in lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Stem Cell Transplantation; Transplantation Conditioning | 2020 |
Substituting carmustine for lomustine is safe and effective in the treatment of relapsed or refractory Lymphoma-a retrospective study from the BSBMT (BEAM versus LEAM).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Humans; Lomustine; Lymphoma; Melphalan; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous | 2021 |
Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Cyclophosphamide; Cytarabine; Lomustine; Lymphoma; Methotrexate; Neoplasm Recurrence, Local | 2021 |
Comparison of Mitoxantrone-Melphalan and BEAM Conditioning Regimens in Patients with Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Mitoxantrone; Transplantation Conditioning; Transplantation, Autologous | 2022 |
Gastrointestinal and oncologic outcomes of pediatric gastrointestinal lymphoma following upfront resection or biopsy of bowel masses.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Digestive System Surgical Procedures; Female; Humans; Ileal Neoplasms; Infant; Lymphoma; Male; Methotrexate; Retrospective Studies | 2021 |
Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma.
Topics: Animals; Antimetabolites, Antineoplastic; Cancer-Associated Fibroblasts; Cell Line, Tumor; Cell Proliferation; Cytarabine; Deoxycytidine; Drug Resistance, Neoplasm; Equilibrative-Nucleoside Transporter 2; Exosomes; Gemcitabine; Humans; Lymphoma; Male; Mice; Mice, Inbred NOD; Mice, SCID; MicroRNAs; Primary Cell Culture; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2021 |
Primary Central Nervous System Lymphomas of the Brain: A Retrospective Analysis in a Single Institution.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Burkitt Lymphoma; Cranial Irradiation; Craniotomy; Cytarabine; Cytoreduction Surgical Procedures; Female; Humans; Injections, Spinal; Kaplan-Meier Estimate; L-Lactate Dehydrogenase; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neurosurgical Procedures; Prognosis; Retrospective Studies; Survival Rate; Young Adult | 2017 |
High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Busulfan; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dacarbazine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma; Male; Methotrexate; Middle Aged; Mucositis; Remission Induction; Retrospective Studies; Rituximab; Stem Cell Transplantation; Temozolomide; Thiotepa; Transplantation Conditioning; Transplantation, Autologous | 2017 |
Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Cytarabine; Dexamethasone; Disease Progression; Female; Humans; Kaplan-Meier Estimate; Lymphoma; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Remission Induction; Rituximab; Survival Analysis; Treatment Outcome; Young Adult | 2017 |
Incidence and prognostic significance of nephrotoxicity in patients receiving eshap as salvage therapy for lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Humans; Incidence; Kaplan-Meier Estimate; Kidney Diseases; Lymphoma; Male; Methylprednisolone; Middle Aged; Outpatients; Prognosis; Proportional Hazards Models; Retrospective Studies; Salvage Therapy; Young Adult | 2017 |
Interim
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Registries; Retrospective Studies; Survival Rate | 2017 |
A dexamethasone, melphalan, actinomycin-D and cytarabine chemotherapy protocol as a rescue treatment for feline lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Cytarabine; Dactinomycin; Dexamethasone; Female; Lymphoma; Male; Melphalan; Salvage Therapy | 2018 |
Efficacy and safety of high-dose etoposide cytarabine as consolidation following rituximab methotrexate temozolomide induction in newly diagnosed primary central nervous system lymphoma in immunocompetent patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Consolidation Chemotherapy; Cytarabine; Etoposide; Humans; Lymphoma; Remission Induction; Survival Analysis; Treatment Outcome | 2018 |
Systematic patient involvement for homebased outpatient administration of complex chemotherapy in acute leukemia and lymphoma.
Topics: Acute Disease; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Female; Humans; Infusion Pumps; Leukemia; Lymphoma; Male; Melphalan; Middle Aged; Outpatients; Podophyllotoxin | 2018 |
High-dose Bendamustine-EAM followed by autologous stem cell rescue results in long-term remission rates in lymphoma patients, without renal toxicity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult | 2018 |
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cohort Studies; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Italy; Lymphoma; Male; Melphalan; Middle Aged; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous | 2018 |
Modified BuCy is an alternative conditioning regimen for lymphoma patients undergoing autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Busulfan; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Semustine; Survival Rate; Transplantation Conditioning | 2019 |
Impact of diverse chemotherapeutic agents and external factors on activation of brown adipose tissue in a large patient collective.
Topics: Adipose Tissue, Brown; Adult; Age Factors; Aged; Antineoplastic Agents; Body Mass Index; Cytarabine; Female; Humans; Lymphoma; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sex Factors | 2019 |
The economic impact of the transition from branded to generic oncology drugs.
Topics: Antineoplastic Agents; Cetuximab; Cisplatin; Cost-Benefit Analysis; Cytarabine; Deoxycytidine; Dexamethasone; Drug Costs; Drugs, Generic; Erlotinib Hydrochloride; Gemcitabine; Humans; Lung Neoplasms; Lymphoma; Randomized Controlled Trials as Topic; Vinorelbine | 2019 |
BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cytarabine; Female; France; Humans; Lymphoma; Male; Melphalan; Middle Aged; Mucositis; Multivariate Analysis; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous | 2019 |
[Our experience with the treatment of primary lymphomas of the central nervous system].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Rituximab; Survival Rate | 2012 |
Fatal cisplatin overdose in the treatment of mediastinal lymphoma with the ESHAP regimen - analysis of the causes of the adverse drug event.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Overdose; Etoposide; Fatal Outcome; Female; Humans; Lymphoma; Mediastinal Neoplasms; Medication Errors; Methylprednisolone | 2013 |
Which regimen is better for stem cell mobilization of lymphoma patients?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Procarbazine; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vinblastine; Vinorelbine | 2013 |
Conditioning regimen with BCNU, etoposide, cytarabine and melphalan plus amifostine for outpatient autologous stem cell transplant: feasibility and outcome in 97 patients with lymphoma.
Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Outpatients; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2014 |
Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neutropenia; Remission Induction; Temozolomide; Thrombocytopenia; Treatment Outcome; Young Adult | 2014 |
Purine analog-like properties of bendamustine underlie rapid activation of DNA damage response and synergistic effects with pyrimidine analogues in lymphoid malignancies.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclophosphamide; Cytarabine; DNA Damage; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Inhibitory Concentration 50; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Multiple Myeloma; Pyrimidines; Rituximab | 2014 |
Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Cytarabine; Dexamethasone; Female; Humans; Idarubicin; Lymphoma; Male; Methotrexate; Middle Aged; Multimodal Imaging; Neoplasm Staging; Prognosis; Rituximab | 2014 |
MATILDE chemotherapy regimen for primary CNS lymphoma: results at a median follow-up of 12 years.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Idarubicin; Lymphoma; Male; Methotrexate; Remission Induction; Thiotepa; Treatment Outcome | 2014 |
Lymphomatosis cerebri: a treatable cause of rapidly progressive dementia.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Dementia; Diffusion Magnetic Resonance Imaging; Female; Humans; Lymphoma; Methotrexate; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiotherapy; Rituximab | 2015 |
Lomustine use in combination with etoposide, cytarabine and melphalan in a brief conditioning regimen for auto-HSCT in patients with lymphoma: the optimal dose.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma; Male; Melphalan; Middle Aged; Transplantation Conditioning; Young Adult | 2014 |
BEAM-conditioned autologous SCT improves the quality of response in Waldenström's macroglobulinaemia and lymphoplasmacytic lymphoma: a single centre's 10-year experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Humans; Lymphoma; Male; Melphalan; Middle Aged; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Waldenstrom Macroglobulinemia | 2014 |
Fotemustine, teniposide and dexamethasone in treating patients with CNS lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dexamethasone; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Radiotherapy, Adjuvant; Teniposide; Young Adult | 2014 |
Single-unit cord blood transplant for acute lymphoblastic leukemia and lymphoma using an intensified conditioning regimen of total body irradiation, high-dose cytarabine and cyclophosphamide.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cytarabine; Female; Follow-Up Studies; Humans; Lymphoma; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation; Young Adult | 2015 |
High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease Progression; Etoposide; Female; France; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Prognosis; Recurrence; Retrospective Studies; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2015 |
Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cytarabine; Disease-Free Survival; Female; Finland; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Rituximab; Survival Rate; Treatment Outcome | 2015 |
Gemcitabine/dexamethasone/cisplatin vs cytarabine/dexamethasone/cisplatin for relapsed or refractory aggressive-histology lymphoma: cost-utility analysis of NCIC CTG LY.12.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Canada; Cisplatin; Clinical Trials as Topic; Cost Savings; Cost-Benefit Analysis; Cytarabine; Deoxycytidine; Dexamethasone; Female; Gemcitabine; Hospital Charges; Hospital Costs; Humans; Lymphoma; Male; Middle Aged; Quality-Adjusted Life Years; Recurrence | 2015 |
Treatment of Primary Central Nervous System Lymphoma with High-dose Methotrexate and Radiotherapy in HIV-negative Patients.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Central Nervous System Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Radiotherapy, Adjuvant; Retrospective Studies; Vincristine | 2015 |
Efficacy and toxicity of carboplatin and cytarabine chemotherapy for dogs with relapsed or refractory lymphoma (2000-2013).
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Dog Diseases; Dogs; Female; Lymphoma; Male; Neutropenia; Recurrence; Retrospective Studies; Thrombocytopenia; Treatment Failure | 2017 |
Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Carmustine; Cytarabine; Disease-Free Survival; Female; Humans; Lymphoma; Male; Melphalan; Middle Aged; Podophyllotoxin; Registries; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Thiotepa | 2016 |
Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Poland; Retrospective Studies; Salvage Therapy; Treatment Outcome; Young Adult | 2016 |
Nanoscale Quantifying the Effects of Targeted Drug on Chemotherapy in Lymphoma Treatment Using Atomic Force Microscopy.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Cytarabine; Elastic Modulus; Humans; Lymphoma; Microscopy, Atomic Force; Models, Biological; Nanomedicine; Rituximab; Single-Cell Analysis; Surface Properties; Tumor Microenvironment | 2016 |
Fertility in premenopausal women post autologous stem cell transplant with BEAM conditioning.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Female; Fertility; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Podophyllotoxin; Premenopause; Retrospective Studies; Transplantation Conditioning; Young Adult | 2016 |
DHAP plus filgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory lymphoma: A single center experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Female; Filgrastim; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Recurrence; Transplantation, Autologous | 2016 |
A retrospective comparison of toxicity and initial efficacy of two autologous stem cell transplant conditioning regimens for relapsed lymphoma: LEAM and BEAM.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma; Male; Melphalan; Middle Aged; Retrospective Studies; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous | 2016 |
Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Febrile Neutropenia; Female; Humans; Lymphoma; Male; Melphalan; Middle Aged; Nausea; Nitrosourea Compounds; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult | 2016 |
Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost-effective.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cost-Benefit Analysis; Cytarabine; Female; Follow-Up Studies; Health Care Costs; Hematopoietic Stem Cell Transplantation; Humans; Infections; Kaplan-Meier Estimate; Lymphoma; Male; Melphalan; Middle Aged; Outpatients; Podophyllotoxin; Transplantation Conditioning; Transplantation, Autologous; Young Adult | 2016 |
High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Disease-Free Survival; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Retrospective Studies; Survival Rate | 2017 |
Psychosexual development and satisfaction in long-term survivors of childhood cancer: Neurotoxic treatment intensity as a risk indicator.
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Case-Control Studies; Cranial Irradiation; Cytarabine; Female; Humans; Injections, Spinal; Leukemia; Lymphoma; Male; Methotrexate; Neoplasms; Neurotoxicity Syndromes; Orgasm; Personal Satisfaction; Psychosexual Development; Reproductive Health; Risk Factors; Sexual Partners; Surveys and Questionnaires; Survivors; Thiotepa; Young Adult | 2017 |
Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Cohort Studies; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Injections, Spinal; Leukemia, Myeloid, Acute; Liposomes; Lymphoma; Male; Meningitis; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Transplantation, Homologous | 2008 |
CP-4055 and CP-4126 are active in ara-C and gemcitabine-resistant lymphoma cell lines.
Topics: Cell Line, Tumor; Cell Membrane; Cytarabine; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Lymphoma | 2009 |
Cytosine arabinoside in addition to VCAA-based protocols for the treatment of canine lymphoma with bone marrow involvement: does it make the difference?
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Neoplasms; Cyclophosphamide; Cytarabine; Dog Diseases; Dogs; Doxorubicin; Female; Lymphoma; Male; Neoplasm Staging; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 2008 |
Avemar, a nontoxic fermented wheat germ extract, attenuates the growth of sensitive and 5-FdUrd/Ara-C cross-resistant H9 human lymphoma cells through induction of apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fluorouracil; Humans; Inhibitory Concentration 50; Lymphoma; Phytotherapy; Plant Extracts | 2009 |
Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma.
Topics: Adult; Aged; Cytarabine; Drug Evaluation; Female; Humans; Injections, Spinal; Liposomes; Lymphoma; Male; Meningeal Carcinomatosis; Middle Aged; Quality of Life; Retrospective Studies | 2009 |
Progress in primary CNS lymphoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials, Phase II as Topic; Cytarabine; Humans; Lymphoma; Methotrexate; Randomized Controlled Trials as Topic | 2009 |
Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Radiotherapy; Retrospective Studies; Treatment Outcome; Vincristine | 2010 |
[Inhibitive effect of artesunate on human lymphoblastic leukemia/lymphoma cells].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Artemisinins; Artesunate; Blood-Brain Barrier; Cell Line, Tumor; Cytarabine; Drug Synergism; Humans; Jurkat Cells; Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2009 |
ESHAP versus rituximab-ESHAP in frail patients with refractory diffuse large B-cell lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cisplatin; Colony-Stimulating Factors; Cytarabine; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Remission Induction; Rituximab | 2010 |
New liposomal cytarabine formulation in CSF.
Topics: Aged; Cytarabine; Humans; Injections, Intraventricular; Injections, Spinal; Liposomes; Lymphoma; Male; Meningitis; Young Adult | 2010 |
Neurologic complications after intrathecal liposomal cytarabine in combination with systemic polychemotherapy in primary CNS lymphoma.
Topics: Aged; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Cytarabine; Drug Therapy, Combination; Female; Humans; Injections, Spinal; Liposomes; Lymphoma; Male; Middle Aged; Nervous System Diseases | 2011 |
A nonradiation-containing, intermediate-dose methotrexate regimen for elderly patients with primary central nervous system lymphoma.
Topics: Aged; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Female; Humans; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Nitrosourea Compounds; Procarbazine; Retrospective Studies | 2010 |
How important is whole brain radiotherapy for treatment of primary CNS lymphoma?
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cranial Irradiation; Cytarabine; Disease-Free Survival; Humans; Ifosfamide; Lymphoma; Methotrexate; Radiotherapy, Adjuvant; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Treatment Outcome | 2010 |
Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Cytarabine; Female; Humans; Injections, Spinal; Leukemia; Liposomes; Lymphoma; Male; Meningeal Neoplasms; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult | 2012 |
FAME, a novel conditioning regimen for allogeneic stem cell transplantation for lymphoma, does not earn fame.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Middle Aged; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2012 |
Platine and cytarabine-based salvage treatment for primary central nervous system lymphoma.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rituximab; Salvage Therapy; Thiotepa; Young Adult | 2011 |
Primary B-cell lymphoma of the cauda equina, successfully treated with high-dose methotrexate plus high-dose cytarabine: a case report with MRI findings.
Topics: Cauda Equina; Cytarabine; Humans; Immunosuppressive Agents; Leukocyte Common Antigens; Lymphoma; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Radiotherapy | 2012 |
Comparison of total body irradiation before and after chemotherapy in pretreatment for hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Lymphoma; Male; Middle Aged; Radiotherapy Dosage; Retrospective Studies; Transplantation Conditioning; Whole-Body Irradiation; Young Adult | 2012 |
CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations.
Topics: Child; Cytarabine; Cytidine Deaminase; Drug Combinations; Exons; Female; Homozygote; Humans; Lymphoma; Mercaptopurine; Methyltransferases; Point Mutation; Polymorphism, Genetic; Promoter Regions, Genetic; Sequence Deletion | 2012 |
High-dose methotrexate and temozolomide associated with intrathecal liposomal cytarabine for the treatment of primary or secondary central nervous system lymphoma: a preliminary experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System Neoplasms; Cytarabine; Dacarbazine; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Nervous System; Temozolomide | 2012 |
Cytosine arabinoside potentiates the apoptotic effect of bendamustine on several B- and T-cell leukemia/lymphoma cells and cell lines.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Bendamustine Hydrochloride; Cell Cycle; Cell Line, Tumor; Cytarabine; Humans; Leukemia; Leukemia, B-Cell; Leukemia, T-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, T-Cell; Nitrogen Mustard Compounds | 2012 |
A new modified prophylactic scheme against liposomal cytarabine-induced arachnoiditis in adult patients with lymphoma.
Topics: Adult; Arachnoiditis; Cytarabine; Humans; Liposomes; Lymphoma; Premedication | 2013 |
Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; British Columbia; Combined Modality Therapy; Cytarabine; Eye Neoplasms; False Positive Reactions; Female; Humans; Incidence; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Predictive Value of Tests; Radiotherapy; Retinal Neoplasms; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Vitrectomy; Vitreous Body | 2013 |
Cytometric evaluation of peripheral blood lymphocytes in dogs with lymphoma during chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cyclophosphamide; Cytarabine; Dog Diseases; Dogs; Female; Flow Cytometry; Immunophenotyping; Lymph Nodes; Lymphocytes; Lymphoma; Male; Prednisolone; Vincristine | 2002 |
Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Humans; Lymphoma; Methotrexate; Procarbazine; Survival Rate; Vincristine | 2002 |
HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death.
Topics: Apoptosis; Benzopyrans; Blast Crisis; Bone Marrow Cells; Cell Death; Cell Survival; Cytarabine; Drug Synergism; Enzyme Inhibitors; Genes, bcl-2; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma; Nitriles; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 2003 |
THE EFFECT OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE HYDROCHLORIDE ON MURINE NEOPLASMS.
Topics: Animals; Anti-Bacterial Agents; Antibodies; Antineoplastic Agents; Blood Cells; Carcinoma, Ehrlich Tumor; Cortisone; Cytarabine; Cytosine; Leukemia L1210; Leukemia, Experimental; Lymphoma; Mercaptopurine; Methotrexate; Mice; Neoplasms; Neoplasms, Experimental; Pharmacology; Research; Sarcoma 180 | 1964 |
Treatment of lymphoma relapses after allogeneic hematopoietic stem cell transplantation with intensive chemotherapy followed by infusion of hematopoietic stem cell from the original donor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Neutropenia; Recurrence; Remission Induction; Thrombocytopenia; Tomography, X-Ray Computed; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2003 |
Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Brain Neoplasms; Cause of Death; Combined Modality Therapy; Confidence Intervals; Cytarabine; Dose Fractionation, Radiation; Female; Follow-Up Studies; Humans; Injections, Intravenous; Injections, Spinal; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Survival Analysis; Time Factors | 2003 |
Use of chemotherapy for treatment of a mixed-cell thoracic lymphoma in a horse.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Female; Horse Diseases; Horses; Immunohistochemistry; Lymphoma; Pleural Effusion, Malignant; Prednisolone; Thoracic Neoplasms | 2004 |
Intensive therapy for aggressive lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Lymphoma; Methotrexate; Prednisone; Stem Cell Transplantation; Vincristine | 2004 |
High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Length of Stay; Lymphoma; Male; Melphalan; Middle Aged; Podophyllotoxin; Prognosis; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2004 |
Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Artificial Gene Fusion; Bone Marrow Transplantation; Cell Line, Tumor; Combined Modality Therapy; Cytarabine; Cytidine Deaminase; Female; Genetic Therapy; Humans; Lymphoma; Methotrexate; Mice; Mice, SCID; Mutation; Retroviridae; Tetrahydrofolate Dehydrogenase; Transplantation, Heterologous | 2004 |
Aggressive systemic mastocytosis mimicking sclerosing cholangitis.
Topics: Abdominal Pain; Adrenal Cortex Hormones; Adult; Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Marrow; Budd-Chiari Syndrome; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Clone Cells; Cytarabine; Diagnosis, Differential; Diarrhea; Fatal Outcome; Female; Flushing; Histamine H1 Antagonists; Humans; Idarubicin; Liver; Lymphoma; Mast Cells; Mastocytosis, Systemic; Mutation, Missense; Point Mutation; Prednisone; Proto-Oncogene Proteins c-kit; Recurrence | 2004 |
[Mobilization of peripheral blood stem cells with mitoxantrone and high-dose cytarabine chemotherapy and rhG-CSF in patients with hematopoietic malignancies].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Lymphoma; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins | 2004 |
Cytotoxic and apoptotic effects of novel heterodinucleoside phosphates consisting of 5-fluorodeoxyuridine and Ara-C in human cancer cell lines.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Bisbenzimidazole; Cell Line, Tumor; Colonic Neoplasms; Coloring Agents; Cytarabine; Dimerization; Dinucleoside Phosphates; Fluorescent Dyes; Fluorouracil; Humans; Inhibitory Concentration 50; Lymphoma; Propidium | 2004 |
The effects of IL-2, IL-6 and IL-10 levels on prognosis in patients with aggressive Non-Hodgkin's Lymphoma (NHL).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Follow-Up Studies; Humans; Interleukin-10; Interleukin-2; Interleukin-6; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Prednisone; Prognosis; Regression Analysis; Time Factors; Treatment Outcome; Vincristine | 2004 |
Effect of pre-transplant cumulative doses of chemotherapeutic drugs on early and long-term hematological recovery after autologous bone-marrow transplantation for lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Bone Marrow; Bone Marrow Transplantation; Carmustine; Chemotherapy, Adjuvant; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Male; Melphalan; Middle Aged; Multivariate Analysis; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous | 2005 |
Cytotoxic effects of novel amphiphilic dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine in cross-resistant H9 human lymphoma cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cytarabine; Dimerization; Floxuridine; Humans; Lymphoma; Phosphorylation | 2005 |
Effect of notch ligands on in vitro sensitivity to chemo-therapeutic drugs in leukemia and lymphoma cells.
Topics: Antineoplastic Agents; Calcium-Binding Proteins; Caspase 3; Caspases; Cell Line, Tumor; Cell Proliferation; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Activation; Humans; Immunoblotting; Intercellular Signaling Peptides and Proteins; Intracellular Signaling Peptides and Proteins; Jagged-1 Protein; Leukemia; Ligands; Lymphoma; Membrane Proteins; Mitoxantrone; NF-kappa B; Phosphorylation; Poly(ADP-ribose) Polymerases; Receptors, Notch; Recombinant Proteins; Serrate-Jagged Proteins; U937 Cells | 2005 |
Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells.
Topics: Adenosine Triphosphate; Apoptosis; Cell Proliferation; Cytarabine; Drug Synergism; Energy Metabolism; Glycolysis; Humans; Leukemia; Lymphoma; Protein Kinases; Sirolimus; TOR Serine-Threonine Kinases; Tumor Cells, Cultured | 2005 |
[Two cases of malignant lymphoma with high fever and C-reactive protein (CRP) elevation after treatment with granulocyte colony-stimulating factor (G-CSF)].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma; Lymphoma, Mantle-Cell; Male; Middle Aged; Prednisone; Recombinant Proteins; Rituximab; Vincristine | 2006 |
Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Camptothecin; Carboplatin; Cell Line, Tumor; Cell Survival; Cyclophosphamide; Cytarabine; Depsipeptides; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Histone Deacetylase Inhibitors; HL-60 Cells; Humans; Imatinib Mesylate; Irinotecan; K562 Cells; Leukemia; Lymphoma; Mercaptopurine; Piperazines; Pyrimidines; Time Factors | 2007 |
Mobilization of peripheral blood progenitor cells after DHAP regimen with or without rituximab: a large multicenter comparative study in patients with malignant lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Female; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma; Male; Middle Aged; Remission Induction; Retrospective Studies; Rituximab; Stem Cells | 2007 |
[The standard treatments for patients with hematological malignancies in Japan].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Melphalan; Multiple Myeloma; Prednisone; Rituximab; Survival Rate; Vincristine | 2007 |
Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carotid Artery, Internal; Catheterization, Peripheral; Cyclophosphamide; Cytarabine; Etoposide; Female; Fluorescein Angiography; Humans; Injections, Spinal; Lymphoma; Male; Mannitol; Methotrexate; Middle Aged; Pigment Epithelium of Eye; Retinal Diseases; Retrospective Studies; Tomography, Optical Coherence; Vertebral Artery | 2007 |
[Comparison of salvage chemotherapy regimen ACES with ESHAP for refractory or relapsed malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytarabine; Etoposide; Female; Humans; Lymphoma; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation | 2007 |
Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Humans; Immunotherapy; Lymphoma; Male; Methotrexate; Middle Aged; Procarbazine; Prospective Studies; Remission Induction; Rituximab; Treatment Outcome; Vincristine | 2007 |
Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Cyclophosphamide; Cytarabine; Etoposide; Fluorescein Angiography; Humans; Injections, Spinal; Lymphoma; Mannitol; Methotrexate; Pigment Epithelium of Eye; Retinal Diseases | 2007 |
Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Line, Tumor; Cytarabine; Deoxycytidine; Drug Interactions; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Hydrazines; Idarubicin; Irinotecan; Leukemia; Lymphoma; Sulfonamides; Topotecan | 2008 |
Analogs of 1-beta-D-arabinofuranosylcytosine. Studies on mechanisms of action in Burkitt's cell culture and mouse leukemia, and in vitro deamination studies.
Topics: Animals; Burkitt Lymphoma; Chromatography, Paper; Culture Techniques; Cytarabine; Cytosine Nucleotides; Drug Antagonism; Drug Synergism; Kidney; Leukemia L1210; Liver; Lymphoma; Mice; Nucleosides; Oxidation-Reduction; Thymidine; Uracil Nucleotides | 1967 |
Clinical pharmacology and human antitumor activity of cytosine arabinoside.
Topics: Adenocarcinoma; Blood Platelets; Carcinoma, Squamous Cell; Cytarabine; Hemoglobinometry; Humans; Leukemia; Leukocyte Count; Lymphoma; Lymphoma, Non-Hodgkin | 1967 |
[Clinical evaluation on the sensitivity test for anti-cancer agents in malignant bone and soft-tissue tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance; Fluorouracil; Histiocytoma, Benign Fibrous; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Osteosarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Succinate Dehydrogenase; Vincristine | 1984 |
[Chemotherapy of non-Hodgkin lymphoma with poor prognosis].
Topics: Antineoplastic Agents; Asparaginase; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Humans; Leucovorin; Lymphoma; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Prognosis; Thioguanine; Vincristine | 1980 |
Nonrandom chromosome abnormalities in angioimmunoblastic lymphadenopathy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Female; Herpes Zoster; Humans; Immunoblastic Lymphadenopathy; Karyotyping; Leucovorin; Lymph Nodes; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine | 1982 |
Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Radiography, Abdominal; Remission, Spontaneous; Time Factors; Vincristine | 1983 |
[Highly malignant non-Hodgkin's lymphoma. Treatment by intensive sequential chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lymphoma; Male; Prednisolone; Prednisone; Prognosis; Teniposide; Thioguanine; Vincristine | 1983 |
[High dose combination chemotherapy (AAABC) and autologous bone marrow transplantation for non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Lymphoma; Male; Middle Aged; Nimustine; Nitrosourea Compounds | 1983 |
[Non-Hodgkin's malignant lymphoma. Therapeutic value of autologous bone marrow transplantation].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Follow-Up Studies; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Thioguanine | 1983 |
Complement-induced entry o f membrane-impermeable material into living tumor cells: possibilities for chemotherapy.
Topics: Animals; Cell Membrane Permeability; Complement System Proteins; Cytarabine; Diphosphonates; Erythrocyte Membrane; Guanosine Monophosphate; Guanosine Triphosphate; Lymphoma; Mice; Osmolar Concentration; Rabbits; Sucrose | 1981 |
Massive BACT chemotherapy with autologous bone marrow transplantation in 17 cases of non-Hodgkin's malignant lymphoma with a very bad prognosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Humans; Lomustine; Lymphoma; Male; Risk; Thioguanine; Whole-Body Irradiation | 1983 |
High-dose cytosine arabinoside in non-Hodgkin's lymphoma.
Topics: Adult; Aged; Bone Marrow; Cytarabine; Female; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged | 1983 |
Autologous bone marrow transplantation in the treatment of poor prognosis non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Freezing; Hematopoiesis; Humans; Lomustine; Lymphoma; Prognosis; Thioguanine; Time Factors; Transplantation, Autologous; Whole-Body Irradiation | 1984 |
High-dose polychemotherapy with autologous bone marrow transplantation in children with relapsed lymphomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Humans; Lymphoma; Male; Nervous System Neoplasms; Recurrence; Thioguanine | 1984 |
Sequential combination of high dose ARA-C (HiDAC) and asparaginase (ASP) for the treatment of advanced acute leukemia and lymphoma.
Topics: Adolescent; Adult; Asparaginase; Cytarabine; Drug Therapy, Combination; Humans; Leukemia; Lymphoma | 1984 |
Radiation recall supraglottitis. A hazard in head and neck chemotherapy.
Topics: Cytarabine; Epiglottitis; Head and Neck Neoplasms; Humans; Laryngitis; Lomustine; Lymphoma; Male; Middle Aged; Radiation Injuries | 1984 |
High-dose cytosine arabinoside. Active agent in treatment of non-Hodgkin's lymphoma.
Topics: Adult; Aged; Bone Marrow; Brain Neoplasms; Cytarabine; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Spinal Cord Neoplasms | 1984 |
Increase of natural killer (NK) activity of mouse lymphocytes following in vitro treatment with cytosine-arabinoside.
Topics: Animals; Cell Adhesion; Cell Line; Cell Survival; Cytarabine; Female; Killer Cells, Natural; Lymphocytes; Lymphoma; Male; Mice; Mice, Inbred C57BL; Spleen; Time Factors | 1984 |
Evaluation of the LSA2L2 protocol for treatment of childhood non-Hodgkin's lymphoma. A report from the Polish Children's Leukemia/Lymphoma Study Group.
Topics: Abdominal Neoplasms; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Leukopenia; Lymphoma; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm Staging; Prednisone; Prognosis; Vincristine | 1984 |
Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid.
Topics: Cytarabine; Drug Administration Schedule; Humans; Kinetics; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma | 1983 |
Phase I and early phase II study of PL-AC [N4-palmitoyl-(1-beta-D-arabinofuranosyl) cytosine] on hematopoietic malignancies.
Topics: Adolescent; Adult; Child; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged | 1984 |
Successful therapy of convoluted T-lymphoblastic lymphoma in the adult.
Topics: Adolescent; Adult; Asparaginase; Brain; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Injections, Spinal; Lomustine; Lymphoma; Male; Mediastinum; Methotrexate; Middle Aged; Prednisone; T-Lymphocytes; Vincristine | 1983 |
The cytarabine syndrome in an adult.
Topics: Aged; Cytarabine; Humans; Lymphoma; Male; Syndrome; T-Lymphocytes | 1983 |
Phase I trial of cytarabine and hydroxyurea.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Child; Cytarabine; Drug Evaluation; Drug Resistance; Female; Gastrointestinal Diseases; Humans; Hydroxyurea; Leukemia; Lymphoma; Male; Middle Aged; Skin Diseases | 1983 |
Primary lymphoma of the brain: a case report and review of the literature.
Topics: Brain Neoplasms; Cytarabine; Female; Humans; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis | 1984 |
Thyroid dysfunction among long-term survivors of bone marrow transplantation.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Humans; Immunologic Deficiency Syndromes; Infant; Leukemia; Lymphoma; Male; Radiation Injuries; Thyroid Diseases; Thyroid Function Tests; Time Factors; Whole-Body Irradiation | 1982 |
[Treatment of malignant lymphoma with single administration of BH-AC (N4-behenoyl-1-beta-D-arabinofuranosylcytosine].
Topics: Adult; Aged; Antineoplastic Agents; Cytarabine; Female; Hodgkin Disease; Humans; Immunoblastic Lymphadenopathy; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged | 1982 |
Leptomeningeal lymphoma: perspectives on management.
Topics: Antineoplastic Agents; Arachnoid; Cytarabine; Humans; Injections, Spinal; Lymphoma; Meningeal Neoplasms; Methotrexate; Pia Mater; Thiotepa | 1981 |
The clinical pharmacology of cytosine arabinoside.
Topics: Cytarabine; Humans; Infusions, Parenteral; Injections, Intravenous; Injections, Subcutaneous; Kinetics; Leukemia; Lymphoma | 1983 |
A phase I-II study of combination therapy with thymidine and cytosine arabinoside.
Topics: Adolescent; Adult; Child; Child, Preschool; Cytarabine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infant; Leukemia; Lymphoma; Male; Middle Aged; Thymidine | 1983 |
[Differential sensitivities of human malignant lymphoma cell lines to anti-cancer drugs].
Topics: Antineoplastic Agents; Cell Differentiation; Cell Line; Cell Survival; Cytarabine; Daunorubicin; DNA, Neoplasm; Doxorubicin; Drug Resistance; Humans; In Vitro Techniques; Lymphoma | 1983 |
Cytostatic drugs are without significant effect on digitoxin plasma level and renal excretion.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Digitoxin; Female; Heart Failure; Humans; Leukemia; Lymphoma; Male; Middle Aged; Prednisone; Procarbazine; Vincristine | 1982 |
Results of LSA2-L2 therapy in 26 children with non-Hodgkin's lymphoma.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dactinomycin; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Injections, Spinal; Lymphoma; Male; Mediastinum; Methotrexate; Vincristine | 1982 |
The cytosine arabinoside (Ara-C) syndrome.
Topics: Adolescent; Child; Child, Preschool; Cytarabine; Female; Fever; Humans; Leukemia, Lymphoid; Lymphoma; Male; Pain; Syndrome | 1981 |
A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
Topics: Adolescent; Adult; Aged; Blood; Bone Marrow; Brain; Brain Neoplasms; Child; Cytarabine; Drug Evaluation; Eye; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Pilot Projects | 1982 |
Use of cytosar in pediatric non-Hodgkin lymphoma.
Topics: Child; Cytarabine; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Lymphoma; Thioguanine | 1982 |
Influence of Ara-C on effector activity of cytotoxic T-lymphocytes in vitro.
Topics: Animals; Cytarabine; Cytotoxicity, Immunologic; Lymphoma; Mice; Neoplasms, Experimental; Spleen; T-Lymphocytes | 1981 |
[Chemotherapy of malignant lymphoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Hodgkin Disease; Humans; Leucovorin; Lymphoma; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vincristine | 1982 |
High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors. A study of 23 patients.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Freezing; Hematopoiesis; Humans; Leukemia; Leukocyte Count; Lomustine; Lymphoma; Male; Middle Aged; Neoplasms; Platelet Count; Thioguanine; Transplantation, Autologous | 1981 |
Uptake of cytosine arabinoside (Ara-C) by LSA lymphoma after irradiation in the stationary phase of growth.
Topics: Adult; Animals; Cell Line; Cell Survival; Cytarabine; Humans; In Vitro Techniques; Lymphoma; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Time Factors | 1982 |
Effect of liposomally trapped antitumour drugs on a drug-resistant mouse lymphoma in vivo.
Topics: Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Cell Survival; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance; Liposomes; Lymphoma; Methotrexate; Mice; Mice, Inbred CBA; Neoplasms, Experimental | 1982 |
Liposomally trapped AraCTP to overcome AraC resistance in a murine lymphoma in vitro.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cell Line; Cytarabine; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance; Liposomes; Lymphoma; Mice; Neoplasms, Experimental; Thymidine | 1982 |
[Therapy of non-Hodgkin lymphomas].
Topics: Antineoplastic Agents; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Humans; Lymphoma; Methotrexate; Prednisone; Procarbazine; Thioguanine; Vincristine | 1982 |
Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity.
Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cell Division; Cell Line; Cells, Cultured; Cytarabine; DNA, Neoplasm; Humans; Hydroxyurea; Leukemia; Lymphoma; Phosphorylation; Thymidine | 1982 |
Salvage chemotherapy for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukopenia; Lomustine; Lymphoma; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Thrombocytopenia | 1982 |
Liposome-cell interactions. A study of the interactions of liposomes containing entrapped anti-cancer drugs with the EMT6, S49 and AE1 (transport-deficient) cell lines.
Topics: Animals; Biological Transport; Cell Line; Cytarabine; Dactinomycin; Female; Liposomes; Lymphoma; Mammary Neoplasms, Experimental; Methotrexate; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Phospholipids; Ribonucleosides; Tubercidin | 1981 |
Influence of C. parvum on the effectiveness of passive serotherapy in the control of the EL4 lymphoma in C57BL/6 mice.
Topics: Animals; Cytarabine; Dose-Response Relationship, Immunologic; Immune Sera; Immunization, Passive; Injections, Intraperitoneal; Injections, Intravenous; Lymphoma; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Propionibacterium acnes | 1980 |
[Intraventricular chemotherapy for treatment of meningeal dissemination from malignant neoplasms (author's transl)].
Topics: Antineoplastic Agents; Cytarabine; Hydrocortisone; Injections, Intraventricular; Leukemia; Lymphoma; Meningeal Neoplasms; Methotrexate; Neoplasm Invasiveness | 1980 |
On heterogeneity of non-Hodgkin's lymphomas as regards sensitivity to cytostatic drugs. An in vitro study.
Topics: Cells, Cultured; Cytarabine; DNA, Neoplasm; Humans; Lymphoma; Melphalan; Prednimustine; Thymidine; Vincristine | 1980 |
[Prognostic changes in juvenile abdominal non-Hodgkin's lympomas (NHL)].
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma; Male; Methotrexate; Prednisone; Prognosis; Thioguanine; Vincristine | 1980 |
Serotherapy of a spontaneous mouse tumour.
Topics: Animals; Cytarabine; Female; Immunization, Passive; Lymphoma; Mice; Mice, Inbred C57BL; Neoplasms, Experimental | 1980 |
Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Cladribine; Colorectal Neoplasms; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; In Vitro Techniques; Leukemia; Lung Neoplasms; Lymphoma; Ribonucleotide Reductases; Tumor Cells, Cultured; Urogenital Neoplasms | 1995 |
Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Length of Stay; Leukapheresis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Vincristine | 1993 |
High-dose chemotherapy and autologous peripheral stem cell transplantation in patients with relapsing malignant lymphomas--first experience in the Slovak Republic.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Lymphoma; Mitoxantrone; Salvage Therapy; Slovakia | 1995 |
Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
Topics: Adult; Antigens, CD; Antigens, CD34; Antigens, Differentiation, Myelomonocytic; Bone Marrow Cells; CD13 Antigens; Cell Separation; Colony-Forming Units Assay; Cytarabine; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-kit; Receptor Protein-Tyrosine Kinases; Receptors, Colony-Stimulating Factor; Sialic Acid Binding Ig-like Lectin 3 | 1995 |
Functional hyperactivity of monocytes after bone marrow transplantation: possible relevance for the development of post-transplant complications or relapse.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biopterins; Bone Marrow Transplantation; Busulfan; Carmustine; Cells, Cultured; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Susceptibility; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Leukemia; Lymphoma; Male; Melphalan; Middle Aged; Monocytes; Neopterin; Podophyllotoxin; Respiratory Burst; Superoxides; Tumor Necrosis Factor-alpha; Whole-Body Irradiation | 1995 |
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cell Separation; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukapheresis; Lymphoma; Male; Middle Aged; Prognosis; Salvage Therapy | 1995 |
[Peripheral blood stem cell transplantation in adult patients].
Topics: Adolescent; Adult; Blood Cell Count; Cell Separation; Chemotherapy, Adjuvant; Cytarabine; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Middle Aged; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1993 |
[Appropriate administration of granulocyte colony stimulating factor for malignant lymphoma of the head and neck].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Doxorubicin; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Leukopenia; Lymphoma; Methotrexate; Prednisone; Teniposide; Vincristine | 1993 |
Effective mobilisation of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: timing of harvesting and composition of the leukapheresis product.
Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Lymphoma; Male; Melphalan; Middle Aged; Salvage Therapy; Time Factors | 1993 |
Viridans streptococcal bacteraemia in patients with neutropenia.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Case-Control Studies; Cytarabine; Environment, Controlled; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Mouth; Neutropenia; Prospective Studies; Risk Factors; Saliva; Streptococcal Infections; Streptococcus | 1995 |
Carmustine, Ara C, cyclophosphamide and etoposide with autologous bone marrow transplantation in relapsed or refractory lymphoma: a dose-finding study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Transplantation, Autologous | 1994 |
[Therapeutic effects of peripheral blood stem cell transplantation following combination chemotherapy using ranimustine, cytarabine, etoposide and cyclophosphamide for patients with hematological malignancies].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Lymphoma; Male; Middle Aged; Nitrosourea Compounds | 1994 |
Bone marrow transplantation in Iran.
Topics: Adolescent; Adult; Anemia, Aplastic; beta-Thalassemia; Bone Marrow Transplantation; Busulfan; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Financing, Personal; Graft vs Host Disease; Humans; Insurance, Health, Reimbursement; Iran; Lymphoma; Male; Melphalan; Middle Aged; Transplantation, Autologous; Transplantation, Homologous | 1994 |
Quality and functional capacity of the bone marrow microenvironment of autologous blood stem cell transplantation (ABSCT) recipients.
Topics: Bone Marrow; Carmustine; Cells, Cultured; Colony-Forming Units Assay; Connective Tissue; Cyclophosphamide; Cytarabine; Etoposide; Graft Survival; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Multiple Myeloma; Transplantation, Autologous; Whole-Body Irradiation | 1994 |
Germ cell failure and Leydig cell insufficiency in post-pubertal males after autologous bone marrow transplantation with BEAM for lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Follicle Stimulating Hormone; Humans; Leydig Cells; Luteinizing Hormone; Lymphoma; Male; Melphalan; Spermatozoa; Transplantation, Autologous | 1994 |
MINE-ESHAP salvage therapy for recurrent and refractory lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Humans; Ifosfamide; Lymphoma; Mesna; Methylprednisolone Hemisuccinate; Mitoxantrone; Neoplasm Recurrence, Local; Salvage Therapy; Survival Rate | 1994 |
E-SHAP: inadequate treatment for poor-prognosis recurrent lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Humans; Lymphoma; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Treatment Outcome | 1993 |
Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, ara-C, cyclophosphamide) +/- TBI and autologous BMT for malignant lymphomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Glomerular Filtration Rate; Hemolytic-Uremic Syndrome; Humans; Kidney; Lymphoma; Male; Middle Aged; Transplantation, Autologous; Whole-Body Irradiation | 1993 |
A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Granulocytes; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukapheresis; Leukocyte Count; Leukocytes, Mononuclear; Lymphoma; Lymphoma, Non-Hodgkin; Macrophages; Male; Melphalan | 1995 |
Effect of modulation of the transferrin receptor on gallium-67 uptake and cytotoxicity in lymphoma cell lines.
Topics: Antineoplastic Agents; Biological Transport; Cell Cycle; Cell Division; Cell Line; Cell Survival; Cytarabine; Flow Cytometry; Gallium Radioisotopes; Gene Expression; Humans; Hydroxyurea; Lymphoma; Methotrexate; Receptors, Transferrin; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1996 |
G-CSF (filgrastim)-stimulated whole blood kept unprocessed at 4 degrees C does support a BEAM-like regimen in bad-risk lymphoma.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cold Temperature; Combined Modality Therapy; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Podophyllotoxin | 1996 |
Peripheral blood stem cell support does not accelerate haemopoietic recovery from miniBEAM chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged | 1996 |
Seeking the nucleoside transporter.
Topics: Animals; Antimetabolites, Antineoplastic; Carrier Proteins; Cell Membrane; Cladribine; Cloning, Molecular; Cytarabine; Deoxycytidine; Erythrocytes; Gemcitabine; Glucose Transporter Type 1; Humans; Leukemia; Lymphoma; Membrane Proteins; Monosaccharide Transport Proteins; Nucleosides; Oocytes; Recombinant Proteins; Uridine; Vidarabine; Xenopus | 1997 |
Long-term survival in primary CNS lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Remission Induction; Survival Analysis; Treatment Outcome | 1998 |
Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Follow-Up Studies; Humans; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Premedication; Radiotherapy Dosage; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 1998 |
Treatment of multifocal lymphoma of bone with intensified ProMACE-CytaBOM chemotherapy and involved field radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Tomography, X-Ray Computed; Vincristine | 1998 |
[Chemotherapy of primary cerebral lymphoma].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cytarabine; Humans; Injections, Spinal; Lymphoma; Methotrexate; Survival Rate; Treatment Outcome | 1997 |
p53 may mediate the mdr-1 expression via the WT1 gene in human vincristine-resistant leukemia/lymphoma cell lines.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Cytarabine; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Genes, p53; Genes, Retinoblastoma; Humans; Leukemia; Lymphoma; Multidrug Resistance-Associated Proteins; Proto-Oncogene Proteins c-myc; RNA, Messenger; RNA, Neoplasm; Transcription Factors; Tumor Cells, Cultured; Vincristine; WT1 Proteins | 1998 |
Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patients.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Colony-Forming Units Assay; Cytarabine; Dexamethasone; Etoposide; Female; Filgrastim; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Lymphoma; Male; Melphalan; Middle Aged; Recombinant Proteins; Retrospective Studies | 1998 |
Factors influencing platelet recovery after autologous transplantation of G-CSF-mobilized peripheral blood stem/progenitor cells following myeloablative therapy in 50 heavily pretreated lymphoma patients.
Topics: Adolescent; Adult; Blood Platelets; Cisplatin; Cytarabine; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Lymphoma; Middle Aged; Myeloablative Agonists; Time Factors; Transplantation, Autologous | 1999 |
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Podophyllotoxin; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 1999 |
Bcl-2 expression correlates with apoptosis induction but not tumor growth delay in transplantable murine lymphomas treated with different chemotherapy drugs.
Topics: Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Lymphoma; Male; Mice; Mice, Inbred C3H; Proto-Oncogene Proteins c-bcl-2 | 1999 |
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclosporine; Cytarabine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoproliferative Disorders; Male; Melphalan; Methotrexate; Middle Aged; Podophyllotoxin; Transplantation Conditioning; Transplantation, Homologous | 2000 |
Primary central nervous system lymphoma: a clinicopathological study of 28 cases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System Neoplasms; Cognition Disorders; Combined Modality Therapy; Cytarabine; Female; Follow-Up Studies; Humans; Injections, Intraventricular; Lymphoma; Male; Methotrexate; Middle Aged; Spinal Cord Neoplasms; Survival Analysis; Time Factors | 2000 |
Automated immature reticulocyte counts are early markers of engraftment following autologous PBSC transplantation in patients with lymphoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Automation; Biomarkers; Carmustine; Cytarabine; Female; Flow Cytometry; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Neutrophils; Podophyllotoxin; Predictive Value of Tests; Reticulocyte Count; Reticulocytes; Time Factors; Transplantation, Autologous | 2000 |
Primary central nervous system lymphoma 1991-1997: outcome and late adverse effects after combined modality treatment.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Female; Humans; Infusions, Intravenous; Lymphoma; Male; Methotrexate; Middle Aged; Radiotherapy; Retrospective Studies; Survival Analysis; Treatment Outcome | 2001 |
Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon.
Topics: Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Humans; Immunoenzyme Techniques; In Situ Hybridization; Killer Cells, Natural; Lymphoma; Male; Methotrexate; Middle Aged; Nose Neoplasms; Prednisone; Radiotherapy; RNA, Viral; Treatment Outcome; Vincristine | 2001 |
Primary isolated lymphoma of the fourth ventricle: case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebral Ventricles; Combined Modality Therapy; Cytarabine; Dexamethasone; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Magnetic Resonance Imaging; Methotrexate | 2001 |
Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Female; Humans; Injections, Intraventricular; Lymphoma; Male; Methotrexate; Middle Aged; Pilot Projects; Survival Analysis; Treatment Outcome | 2001 |
Molecular remission following high-dose hydroxyurea and fludarabine plus cytarabine in a patient with simultaneous acute myeloid leukemia and low-grade lymphoma.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Hydroxyurea; Leukemia, Myeloid; Lymphoma; Neoplasms, Multiple Primary; Remission Induction; Vidarabine | 2001 |
Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Prognosis; Radiopharmaceuticals; Survival Analysis; Survival Rate; Tomography, Emission-Computed; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 2002 |
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Purging; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, bcl-2; Half-Life; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Male; Metabolic Clearance Rate; Middle Aged; Polymerase Chain Reaction; Prednisone; Recurrence; Rituximab; Transplantation, Autologous; Vincristine | 2002 |
Green urine in a critically ill patient.
Topics: Adult; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Cytarabine; Humans; Lymphoma; Male; Neutropenia; Sepsis; Urine | 2002 |
Reversible changes in duodenal mucosa associated with intensive chemotherapy followed by autologous marrow rescue.
Topics: Antineoplastic Agents; Bone Marrow Transplantation; Child, Preschool; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Duodenum; Humans; Ileal Neoplasms; Intestinal Mucosa; Lymphoma; Male; Transplantation, Autologous; Vincristine | 1979 |
Meningeal involvement in leukemias and malignant lymphomas of adults: incidence, course of disease, and treatment for prevention.
Topics: Adult; Cytarabine; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Meningeal Neoplasms; Methotrexate; Prognosis; Retrospective Studies; Time Factors | 1979 |
Growth inhibition of normal or drug-treated lymphoma cells in lethally irradiated mice.
Topics: Animals; Antigens, Neoplasm; Cytarabine; Dacarbazine; Female; Graft Rejection; H-2 Antigens; Immunity; Lymphoma; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Homologous; Triazenes | 1978 |
Two dimensional view of combination chemotherapy in vitro.
Topics: Cell Line; Cell Survival; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Lymphocytes; Lymphoma; Methotrexate; Prednisolone; Vincristine | 1978 |
Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma.
Topics: Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission, Spontaneous; Time Factors; Vincristine | 1976 |
[Therapeutical evaluation of two chemotherapy regimens in 38 non-Hodgkin lymphomas (author's transl)].
Topics: Antineoplastic Agents; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Humans; Lymphoma; Male; Prednisone; Vincristine | 1977 |
Drugs five years later: cytarabine.
Topics: Acute Disease; Adult; Animals; Bone Marrow Diseases; Central Nervous System Diseases; Cyclophosphamide; Cytarabine; Daunorubicin; DNA, Neoplasm; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Prednisone; Remission, Spontaneous; Thioguanine; Vincristine; Virus Diseases | 1975 |
Non-Hodgkin's lymphoma in children: results of treatment with LSA2-L2 protocol.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Lymph Nodes; Lymphoma; Male; Mediastinal Neoplasms; Methotrexate; Nasopharyngeal Neoplasms; Ovarian Neoplasms; Skin Neoplasms; Stomach Neoplasms; Thioguanine; Vincristine | 1975 |
1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
Topics: Carmustine; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Prednisone; Procarbazine; Remission, Spontaneous; Vincristine | 1975 |
Non-Hodgkin's lymphoma in children.
Topics: Adolescent; Asparaginase; Bone Marrow; Brain Neoplasms; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Hydroxyurea; Lymphoma; Male; Methotrexate; Neoplasm Metastasis; Nitrogen Mustard Compounds; Peripheral Nervous System Neoplasms; Prednisone; Prognosis; Thioguanine; Vincristine | 1975 |
Letter: Intravenous cytarabine in treatment of herpes zoster in haematological malignancy.
Topics: Adolescent; Adult; Aged; Child; Cytarabine; Female; Herpes Zoster; Humans; Leukemia; Lymphoma; Male; Middle Aged | 1976 |
Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Lymphoma; Male; Mercaptopurine; Methotrexate; Neoplasm Metastasis; Prednisone; Thioguanine; Vinblastine; Vincristine | 1976 |
Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte-colony stimulating factor.
Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Blood Component Removal; Blood Transfusion, Autologous; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma; Male; Middle Aged; Recombinant Proteins | 1992 |
Neuropsychologic impairment in adult bone marrow transplant candidates.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Attention; Bone Marrow Transplantation; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Cognition Disorders; Cranial Irradiation; Cytarabine; Female; Humans; Leukemia; Lymphoma; Male; Memory; Methotrexate; Middle Aged; Neuropsychology; Psychomotor Performance; Regression Analysis; Whole-Body Irradiation | 1992 |
Polyneuritis after HD Ara-C therapy for malignant lymphoma.
Topics: Adult; Cytarabine; Female; Humans; Lymphoma; Polyneuropathies | 1992 |
Effect of the dosing interval on myelotoxicity and survival in mice treated by cytarabine.
Topics: Animals; Bone Marrow; Cell Cycle; Cytarabine; Drug Administration Schedule; Lymphoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Tumor Cells, Cultured | 1992 |
Pneumothorax following cytotoxic chemotherapy in malignant lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Humans; Lung; Lung Neoplasms; Lymphoma; Male; Methotrexate; Middle Aged; Pneumothorax; Prednisone; Procarbazine; Radiography; Vinblastine; Vincristine | 1990 |
Pharmacokinetics of ara-C and ara-U in plasma and CSF after high-dose administration of cytosine arabinoside.
Topics: Arabinofuranosyluracil; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Female; Half-Life; Humans; Lymphoma; Male; Metabolic Clearance Rate; Middle Aged | 1992 |
Experience with salvage regimens at M.D. Anderson Hospital.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Evaluation; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Mesna; Methotrexate; Methylprednisolone; Methylprednisolone Hemisuccinate; Mitoguazone; Mitoxantrone; Remission Induction; Survival Rate | 1991 |
Role of levamisole as immunomodulant in mouse lymphoma model.
Topics: Animals; Carmustine; Cytarabine; Dacarbazine; Drug Synergism; Female; Immune Tolerance; Levamisole; Lymphoma; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Transplantation, Homologous | 1991 |
Lymphomatous polyneuropathy. Biopsy of clinically involved nerve and successful treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Cytarabine; Electrophysiology; Female; Humans; Leg; Leucovorin; Lymphoma; Methotrexate; Nervous System; Nervous System Neoplasms; Vincristine | 1991 |
Ophthalmological and other toxicities related to cytosine arabinoside and total body irradiation as preparative regimen for bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cerebellar Diseases; Cyclosporins; Cytarabine; Diarrhea; Evaluation Studies as Topic; Female; Georgia; Humans; Leukemia; Lymphoma; Male; Methotrexate; Myelodysplastic Syndromes; Preoperative Care; Remission Induction; Retinitis; Survival Rate; Transplantation, Autologous; Transplantation, Homologous; Whole-Body Irradiation | 1990 |
Regulation of the cytidine phospholipid pathways in human cancer cells and effects of 1-beta-D-arabinofuranosylcytosine: a noninvasive 31P nuclear magnetic resonance study.
Topics: Basement Membrane; Breast Neoplasms; Cytarabine; Humans; In Vitro Techniques; Lymphoma; Magnetic Resonance Spectroscopy; Nucleotidyltransferases; Phosphatidylcholines; Phosphatidylethanolamines; Phosphoric Diester Hydrolases; Tumor Cells, Cultured | 1990 |
[Management results of primary intracranial malignant lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Combined Modality Therapy; Cytarabine; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Lymphoma; Male; Methotrexate; Middle Aged; Nimustine; Prognosis; Radiotherapy Dosage | 1990 |
Analysis of factors affecting hematopoietic recovery after autologous bone marrow transplantation for lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Cytarabine; Dexamethasone; Drug Therapy, Combination; Female; Hematopoiesis; Hematopoietic Stem Cells; Humans; Lymphoma; Male; Middle Aged; Transplantation, Autologous | 1990 |
BVAC ablative chemotherapy followed by autologous bone marrow transplantation for patients with advanced lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Humans; Lymphoma; Middle Aged; Survival Analysis; Time Factors | 1990 |
Salvage therapy with methyl-gag, high-dose Ara-C, M-Amsa, and ifosfamide (MAMI) for recurrent or refractory lymphoma.
Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Mitoguazone; Pilot Projects | 1990 |
Comparative studies of the preparation of immunoliposomes with the use of two bifunctional coupling agents and investigation of in vitro immunoliposome-target cell binding by cytofluorometry and electron microscopy.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Cross-Linking Reagents; Cytarabine; Drug Carriers; Flow Cytometry; Immunotoxins; Liposomes; Lymphoma; Maleimides; Mice; Microscopy, Electron; Microscopy, Electron, Scanning; Prodrugs; Rats; Succinimides; Sulfides; T-Lymphocytes; Tumor Cells, Cultured | 1990 |
High-dose cytosine arabinoside-associated pancreatitis.
Topics: Adult; Amylases; Cytarabine; Female; Humans; Isoenzymes; Leukemia; Lipase; Lymphoma; Nausea; Pain; Pancreatitis; Retrospective Studies | 1985 |
Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Teniposide; Vincristine | 1986 |
Treatment of intraocular lymphoma with high-dose Ara-C.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Eye Neoplasms; Female; Humans; Lymphoma; Middle Aged; Neoplasm Recurrence, Local; Palliative Care | 1986 |
DNA methylating activity in murine lymphoma cells xenogenized by triazene derivatives.
Topics: Animals; Azacitidine; Carmustine; Cell Line; Cytarabine; Dacarbazine; DNA, Neoplasm; Lymphoma; Male; Methylation; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Quinacrine; Triazenes | 1987 |
AIDS-related malignant lymphoma: results of prospective treatment trials.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Vincristine | 1987 |
Acute myeloid leukaemia presenting with pleural effusions.
Topics: Antigens, Differentiation; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diagnosis, Differential; Histocompatibility Antigens; Humans; Leukemia, Myeloid, Acute; Leukocyte Common Antigens; Lymph Nodes; Lymphoma; Male; Middle Aged; Mitoxantrone; Pleural Effusion; Remission Induction | 1989 |
The role of peripheral blood stem cells as rescue after myeloablative therapy.
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Combined Modality Therapy; Cytarabine; Daunorubicin; Evaluation Studies as Topic; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Leukemia, Myeloid, Acute; Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Transplantation, Autologous | 1989 |
Use of anti-idiotypic antibody-drug conjugates to treat experimental murine B-cell tumors.
Topics: Animals; Antibodies, Anti-Idiotypic; Antineoplastic Agents; B-Lymphocytes; Cisplatin; Cytarabine; Daunorubicin; Doxorubicin; Immunoglobulin M; Lymphoma; Mice; Tumor Cells, Cultured | 1989 |
Central nervous system involvement in haematological malignancies.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Humans; Injections, Spinal; Leukemia; Lymphoma; Meningeal Neoplasms; Methotrexate; Remission Induction; Spinal Neoplasms | 1989 |
Results of treatment in children with B-cell lymphoma: report on the Polish Leukemia/Lymphoma Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Infant; Lymphoma; Methotrexate; Retrospective Studies; Vincristine | 1989 |
Chemotherapy in the management of intraocular lymphoma.
Topics: Adult; Aged; Combined Modality Therapy; Cytarabine; Drug Evaluation; Eye Neoplasms; Female; Humans; Infusions, Intravenous; Lymphoma; Male; Middle Aged | 1989 |
Deoxycytidine is salvaged not only into DNA but also into phospholipid precursors. II. Ara-C does not inhibit the later process in lymphoid cells.
Topics: AraC Transcription Factor; Bacterial Proteins; Choline; Cytarabine; Deoxycytidine; DNA; Humans; Infant; Lymphoid Tissue; Lymphoma; Phospholipids; Repressor Proteins; Thymidine; Transcription Factors; Tumor Cells, Cultured | 1989 |
Immunospecific targeting of cytosine arabinonucleoside-containing liposomes to the idiotype on the surface of a murine B-cell tumor in vitro and in vivo.
Topics: Animals; Antigen-Antibody Reactions; B-Lymphocytes; Bromodeoxyuridine; Cytarabine; Female; Immunoglobulin Idiotypes; Liposomes; Lymphoma; Mice; Mice, Inbred BALB C; Peritoneal Neoplasms; Surface Properties | 1989 |
Pharmacology studies of 1-beta-D-arabinofuranosylcytosine in pediatric patients with leukemia and lymphoma after a biochemically optimal regimen of loading bolus plus continuous infusion of the drug.
Topics: Adolescent; Child; Child, Preschool; Cytarabine; Deoxycytidine Kinase; Humans; Infant; Leukemia; Lymphoma | 1989 |
Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosi
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Neutropenia; Peripheral Nervous System Diseases; Prednisone; Prognosis; Thrombocytopenia; Vincristine | 1986 |
Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Evaluation; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Methylprednisolone; Mitoguazone; Transplantation, Autologous | 1988 |
Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematologic Diseases; Humans; Leukemia, Lymphoid; Lymphoma; Male; Melphalan; Middle Aged; Recurrence; Remission Induction; Thymoma; Thymus Neoplasms | 1988 |
Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal brain lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain; Brain Neoplasms; Cisplatin; Cytarabine; Dexamethasone; Female; Humans; Lymphoma; Male; Middle Aged | 1988 |
[BH-AC.AMP protocol in the treatment of refractory childhood acute leukemia].
Topics: Aclarubicin; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Female; Humans; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma; Male; Mercaptopurine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction | 1988 |
Ifosfamide and VP-16213 combination chemotherapy combined with ablative chemotherapy and autologous marrow transplantation as salvage treatment for malignant lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Humans; Ifosfamide; Lymphoma; Melphalan; Methotrexate; Middle Aged; Mitoguazone; Podophyllotoxin | 1988 |
Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.
Topics: Adolescent; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cytarabine; Humans; Leukemia; Lymphoma; Whole-Body Irradiation | 1987 |
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Cytarabine; Dexamethasone; Drug Evaluation; Humans; Lymphoma; Middle Aged; Multiple Organ Failure; Nervous System Diseases | 1988 |
Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cytarabine; Drug Administration Schedule; Female; Humans; Leukemia, Lymphoid; Lymphoma; Male; Meningeal Neoplasms; Methotrexate; Middle Aged | 1986 |
Staging and therapy of orbital lymphomas.
Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Orbital Neoplasms; Prednisone; Prognosis; Radionuclide Imaging; Vincristine | 1986 |
Modified cyclophosphamide, vincristine, methotrexate, leucovorin, and cytarabine (COMLA) in intermediate- and high-grade lymphoma: an effective short-course regimen.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Vincristine | 1986 |
Very high dose chemotherapy with autologous bone marrow rescue in adult patients with resistant relapsed lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Female; Hodgkin Disease; Humans; Lymphoma; Male; Melphalan; Methotrexate; Middle Aged; Podophyllotoxin | 1986 |
Cerebellar toxicity with high-dose cytosine arabinoside.
Topics: Adolescent; Adult; Age Factors; Aged; Cerebellar Diseases; Child; Child, Preschool; Cytarabine; Female; Humans; Infant; Leukemia; Lymphoma; Male; Middle Aged | 1987 |
CYTOSAR-U sterile powder: therapeutic biological effects. Proceedings of a symposium. November 30-December 2, 1986, Kalamazoo, MI.
Topics: Acute Disease; Animals; Cytarabine; Humans; Leukemia; Lymphoma | 1987 |
Phase I clinical and pharmacokinetic study of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
Topics: Adult; Aged; Antineoplastic Agents; Cytarabine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Tolerance; Female; Hematopoiesis; Humans; Kinetics; Leukemia; Lymphoma; Male; Metabolic Clearance Rate; Middle Aged | 1986 |
Antimetabolites in combination with other drugs improve therapy of diffuse aggressive non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Humans; Lymphoma; Methotrexate; Pilot Projects; Risk | 1986 |
[High dose cytosine arabinoside (HDCA) in children with refractory leukemia or malignant lymphoma (3 g/m2 vs 1.5 g/m2)].
Topics: Adolescent; Child; Cytarabine; Female; Humans; Kinetics; Leukemia; Lymphoma; Male | 1985 |
A novel treatment of childhood lymphoblastic non-Hodgkin's lymphoma: early and intermittent use of teniposide plus cytarabine.
Topics: Adolescent; Child; Child, Preschool; Cytarabine; Drug Therapy, Combination; Female; Humans; Infant; Injections, Spinal; Lymphoma; Male; Methotrexate; Podophyllotoxin; Prognosis; Teniposide; Thymus Gland | 1985 |
High-dose cytosine arabinoside in the treatment of childhood malignancies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Child; Child, Preschool; Cytarabine; Diterpenes; Doxorubicin; Female; Humans; Infant; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Pancytopenia; Recurrence; Retinyl Esters; Vitamin A; Vomiting | 1985 |
[Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
Topics: Adult; Asparaginase; Cytarabine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged | 1985 |
[High-dose cytosine arabinoside administration in the treatment of refractory leukemia].
Topics: Adolescent; Adult; Cytarabine; Drug Administration Schedule; Female; Humans; Leukemia; Leukemia, Myeloid; Lymphoma; Male; Middle Aged | 1985 |
Continuous infusion of high-dose cytosine arabinoside for treatment of childhood acute leukemia and non-Hodgkin's lymphoma in relapse.
Topics: Acute Disease; Adolescent; Adult; B-Lymphocytes; Bacterial Infections; Burkitt Lymphoma; Cerebellar Ataxia; Child; Child, Preschool; Cytarabine; Female; Gastrointestinal Diseases; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Male; Neutropenia; Recurrence; Thrombocytopenia | 1985 |
High-dose adriamycin combination chemotherapy for intermediate and high-grade non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Lymphoma; Male; Middle Aged; Neutropenia; Prednisone; T-Lymphocytes; Thrombocytopenia; Vincristine | 1985 |
Production of colony stimulating factor by EL-4 lymphoma cells stimulated with phytohemoagglutinin.
Topics: Animals; Bone Marrow Cells; Cell Differentiation; Cell Line; Colony-Forming Units Assay; Colony-Stimulating Factors; Cytarabine; Female; Kinetics; Lymphocyte Activation; Lymphoma; Mice; Mice, Inbred BALB C; Phytohemagglutinins; T-Lymphocytes | 1985 |
Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Female; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Vincristine | 1985 |
[Principles of high-dose cytarabinoside treatment].
Topics: Acute Disease; Bone Marrow; Cell Cycle; Cytarabine; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Metabolic Clearance Rate; RNA, Neoplasm | 1985 |
[Results of high-dose cytarabine therapy. A review].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dose-Response Relationship, Drug; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma | 1985 |
Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Central Nervous System Diseases; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Diarrhea; Graft vs Host Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Pulmonary Fibrosis; Skin Diseases; Whole-Body Irradiation | 1985 |
Central nervous system toxicity with high-dose cytosine arabinoside.
Topics: Acute Disease; Aging; Central Nervous System Diseases; Combined Modality Therapy; Cytarabine; Drug Evaluation; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Middle Aged; Whole-Body Irradiation | 1985 |
Autologous bone marrow transplantation with marrow decontaminated by immunotoxin T 101 in the treatment of leukemia and lymphoma: first clinical observations.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Cytotoxicity, Immunologic; Drug Evaluation; Female; Hematopoietic Stem Cells; Humans; Leukemia, Lymphoid; Lymphoma; Male; Mediastinal Neoplasms; Prognosis; Ricin; Specimen Handling; Whole-Body Irradiation | 1985 |
Synergistic effect of radiation and N-nitrosoethylurea in the induction of lymphoma in mice: cellular kinetics and carcinogenesis.
Topics: Animals; Bone Marrow; Cocarcinogenesis; Cytarabine; DNA; Ethylnitrosourea; Female; Lymphoma; Methylation; Mice; Mice, Inbred C57BL; Neoplasms, Radiation-Induced; Nitrosourea Compounds; Thymus Gland | 1985 |
[Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Leukemia; Lymphoma; Male; Myeloproliferative Disorders; Podophyllotoxin | 1986 |
[ABEP chemotherapy in the treatment of advanced non-Hodgkin's lymphomas].
Topics: Aclarubicin; Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Naphthacenes; Prednisolone; Thrombocytopenia; Vincristine | 1986 |
Successful high-dose intravenous cytarabine treatment of parenchymal brain involvement from malignant lymphoma.
Topics: Brain Neoplasms; Corpus Callosum; Cytarabine; Female; Frontal Lobe; Humans; Infusions, Parenteral; Lymphoma; Middle Aged; Spinal Neoplasms | 1986 |
Analysis of the drug synergism between thymidine and arabinosyl cytosine using mouse S49 T lymphoma mutants.
Topics: Animals; Cells, Cultured; Cytarabine; Deoxycytosine Nucleotides; Drug Synergism; Lymphoma; Mice; Mutation; Thymidine; Thymine Nucleotides | 1985 |
Treatment of diffuse aggressive non-Hodgkin's lymphomas with an intensive multi-drug regimen including high-dose cytosine arabinoside (F-MACHOP).
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Recurrence; Vincristine | 1985 |
The use of high-dose cytosine arabinoside for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Cytarabine; Doxorubicin; Humans; Lymphoma; Middle Aged; Neutropenia; Prednisolone; Recurrence; Skin Diseases; Thrombocytopenia; Vincristine | 1985 |
High-dose cytosine arabinoside in previously treated patients with poor-prognosis non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Cytarabine; Female; Humans; Lymphoma; Male; Middle Aged; Prognosis | 1985 |
Cytarabine-cis-platin interactions in patients with advanced cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Carcinoma, Bronchogenic; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Kidney Diseases; Leukopenia; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia | 1985 |
A two-stage therapeutic design in the spontaneous AKR lymphoma system.
Topics: Amides; Animals; Antineoplastic Agents; Azacitidine; Cyclic P-Oxides; Cyclophosphamide; Cytarabine; Disease Models, Animal; Drug Combinations; Female; Imidazoles; Lymphoma; Male; Mercaptopurine; Methotrexate; Mice; Mice, Inbred Strains; Oxazines; Prednisone; Remission, Spontaneous; Time Factors; Triazenes; Vincristine | 1972 |
Cytosine arabinoside in herpes zoster.
Topics: Adult; Aged; Cytarabine; Female; Herpes Zoster; Humans; Lymphoma; Male; Middle Aged | 1973 |
Antibody reactions to herpesvirus saimiri (HVS)-induced early and late antigens (EA and LA) in HVS-infected squirrel, marmoset and owl monkeys.
Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Viral; Antibody Formation; Antigen-Antibody Complex; Antigen-Antibody Reactions; Antigens, Viral; Cells, Cultured; Culture Media; Cytarabine; Fluorescent Antibody Technique; Haplorhini; Herpesviridae; Immune Sera; Immunoglobulin E; Leukocyte Count; Lymphocytes; Lymphoma; Neoplasm Transplantation; Neoplasms, Experimental; Oncogenic Viruses; Staining and Labeling; Time Factors; Transplantation, Homologous | 1973 |
Metabolic inhibitors and viral lymphomagenesis in thymic grafts.
Topics: Animals; Antimetabolites; Cytarabine; Dactinomycin; Female; Immunity; Leukemia Virus, Murine; Lymphoma; Male; Mice; Puromycin; Regeneration; Rifampin; Streptonigrin; Streptovaricin; Thymectomy; Thymus Gland | 1974 |
Chemotherapy of Herpesvirus saimiri induced lymphoma-leukemia in the owl monkey.
Topics: Adenine; Animals; Arabinose; Cyclophosphamide; Cytarabine; Disease Models, Animal; Haplorhini; Herpesviridae; Hydrocortisone; Interferons; Leukemia, Lymphoid; Leukocyte Count; Lymphoma; Monkey Diseases; Oncogenic Viruses; Vincristine; Virus Replication | 1974 |
Polynucleotide ligase activity in cells infected with simian virus 40, polyoma virus, or vaccinia virus.
Topics: Animals; Carbon Isotopes; Cell Line; Cell Nucleus; Chick Embryo; Cricetinae; Cytarabine; Cytoplasm; DNA Replication; DNA, Viral; Embryo, Mammalian; Fibroblasts; Haplorhini; HeLa Cells; Humans; Kidney; Ligases; Lymphoma; Mice; Neoplasms, Experimental; Polyomavirus; Puromycin; Rifampin; Simian virus 40; Thymoma; Vaccinia virus | 1969 |
Spontaneous AK leukemia (lymphoma) as a model for human leukemias and lymphomas.
Topics: Animals; Cyclophosphamide; Cytarabine; Disease Models, Animal; Drug Combinations; Leukemia Virus, Murine; Leukemia, Experimental; Lymphoma; Mice; Mice, Inbred Strains; Remission, Spontaneous; Thymectomy; Time Factors; Vincristine | 1972 |
The repair of methyl methanesulphonate-induced lesions in the DNA of a murine lymphoma cell.
Topics: Animals; Cell Line; Centrifugation, Density Gradient; Cytarabine; Deoxycytidine; DNA Repair; DNA Replication; DNA, Single-Stranded; Hydroxyurea; Lymphocytes; Lymphoma; Mesylates; Mice; Mice, Inbred Strains; Radiation Effects; Spectrophotometry, Ultraviolet; Tritium | 1973 |
The combined effect of drugs and tumor-specific antibodies in protection against a mouse lymphoma.
Topics: Animals; Antibodies, Neoplasm; Chlorambucil; Cytarabine; Immune Sera; Immunotherapy; Lymphoma; Melphalan; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Rabbits; Time Factors | 1974 |
Enhancement of the cancer chemotherapeutic effect of the cell cycle phase specific agents methotrexate and cytosine arabinoside when given as a water-oil-water emulsion.
Topics: Animals; Carcinoma 256, Walker; Cytarabine; Emulsions; Lymphoma; Methotrexate; Mice; Neoplasms, Experimental; Squalene; Time Factors; Water | 1974 |
Combination chemotherapy for spontaneous AKR lymphoma.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Disease Models, Animal; Doxorubicin; Drug Therapy, Combination; Lymphoma; Methotrexate; Mice; Mice, Inbred AKR; Neoplasms, Experimental; Nitrosourea Compounds; Organ Size; Palmitic Acids; Prednisone; Remission, Spontaneous; Rodent Diseases; Spleen; Splenomegaly; Thymus Gland; Time Factors; Vincristine | 1974 |
In vitro-in vivo correlation of drug metabolism--deamination of 1- -D-arabinofuranosylcytosine.
Topics: Aminohydrolases; Carbon Isotopes; Cytarabine; Deamination; Female; Humans; Kinetics; Leukemia, Myeloid; Lymphoma; Male; Mathematics; Models, Biological; Uracil | 1972 |
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Models, Animal; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fluorouracil; Hodgkin Disease; Humans; Leukemia; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Mechlorethamine; Melphalan; Mice; Mice, Inbred AKR; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Remission, Spontaneous; Vinblastine; Vincristine | 1974 |
Mediastinal adenopathy in granulocytic leukemia.
Topics: Adult; Busulfan; Cytarabine; Diagnosis, Differential; Female; Humans; Leukemia, Myeloid; Lymph Nodes; Lymphoma; Male; Mediastinal Neoplasms; Thioguanine | 1974 |
Alterations of granulopoiesis following chemotherapy.
Topics: Adult; Aged; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Cell Division; Clone Cells; Cytarabine; DNA; Doxorubicin; Female; Glycoproteins; Hematopoiesis; Humans; Leukemia, Myeloid, Acute; Lymphoma; Male; Mitosis; Muramidase; Thioguanine; Thymidine; Tritium | 1974 |
Blood and neoplastic diseases. Rational approach to the chemotherapy of human malignant disease-II.
Topics: Antineoplastic Agents; Brain Neoplasms; Busulfan; Cell Count; Cell Division; Cytarabine; Diffusion; Drug Tolerance; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukocyte Count; Lymphoma; Methotrexate; Multiple Myeloma; Neoplasms; Vincristine | 1974 |
The effects of arabinosylcytosine on cultured human lymphoma cells.
Topics: Aminohydrolases; Cell Line; Cell Survival; Cytarabine; DNA Replication; Dose-Response Relationship, Drug; Humans; Lymphoma; Phosphotransferases; Thymidine; Time Factors; Tritium | 1972 |
Effects of inhibitors of protein and nucleic acid synthesis on the expression of H-2 and Moloney leukemia virus-determined cell-surface antigens on cultured murine lymphoma cells.
Topics: Animals; Antigens; Antigens, Neoplasm; Antigens, Viral; Antineoplastic Agents; Cell Membrane; Cells, Cultured; Culture Media; Cycloheximide; Cytarabine; Dactinomycin; Histocompatibility Antigens; Hydroxyurea; Lymphoma; Mice; Mitomycins; Moloney murine leukemia virus; Neoplasm Proteins; Neoplasms, Experimental; Puromycin; RNA, Neoplasm | 1972 |
Action of 1- -D-arabinofuranosylcytosine on mammalian tumor cells. 1. Incorporation into DNA.
Topics: Animals; Cells, Cultured; Centrifugation, Density Gradient; Chromatography, Thin Layer; Cytarabine; DNA, Neoplasm; Lymphoma; Mice; Tritium | 1972 |
Chemotherapy of malignant lymphoma with adriamycin.
Topics: Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Hematopoietic System; Hodgkin Disease; Humans; Injections, Intravenous; Leukemia; Lymphoma; Prednisone; Remission, Spontaneous; Vincristine | 1973 |
The clinical uses of cytosine arabinoside in retinoblastoma and lymphoma.
Topics: Adult; Aged; Child; Child, Preschool; Cytarabine; Eye Neoplasms; Female; Follow-Up Studies; Humans; Lymphoma; Male; Middle Aged; Remission, Spontaneous; Retinoblastoma | 1973 |
Combination chemotherapy: the antagonism of methotrexate and cytosine arabinoside.
Topics: Animals; Cell Line; Cytarabine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Lymphoma; Methotrexate; Mice | 1973 |
Multiple emulsions, a suitable vehicle to provide sustained release of cancer chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Cytarabine; Delayed-Action Preparations; Diarrhea; Emulsions; Lymphoma; Methotrexate; Mice; Neoplasms, Experimental; Pharmaceutical Vehicles; Rats; Vinblastine; Vomiting | 1972 |
Action of 1- -D-arabinofuranosylcytosine on mammalian tumor cells. 2. Inhibition of mammalian and oncogenic viral polymerases.
Topics: Animals; Cell Transformation, Neoplastic; Cells, Cultured; Cytarabine; DNA Nucleotidyltransferases; Leukemia; Liver; Lymphoma; Mice; Oncogenic Viruses; Rauscher Virus | 1972 |
Leukemia and lymphoma.
Topics: Antineoplastic Agents; BCG Vaccine; Burkitt Lymphoma; Busulfan; Chlorambucil; Cyclophosphamide; Cytarabine; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Prednisone; Vincristine | 1970 |
Cytarabine.
Topics: Acute Disease; Amino Sugars; Anemia; Antibiotics, Antineoplastic; Antineoplastic Agents; Blood Cell Count; Cyclophosphamide; Cytarabine; Glycosides; Humans; Injections, Intravenous; Injections, Subcutaneous; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukopenia; Lymphoma; Prednisone; Remission, Spontaneous; Thioguanine; Thrombocytopenia; Vincristine | 1971 |
Response to therapy of spontaneous, first passage, and long passage lines of AK leukemia.
Topics: Age Factors; Animals; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Leukemia L1210; Leukemia, Experimental; Lymphoma; Mice; Time Factors; Vincristine | 1969 |
Reduction of colony-forming cell sensitivity to arabinosylcytosine by halothane anesthesia.
Topics: Anesthesia, Inhalation; Animals; Bone Marrow; Bone Marrow Cells; Cell Division; Cytarabine; Drug Synergism; Female; Halothane; Lymphoma; Mice; Neoplasms, Experimental; Nitrous Oxide; Splenic Neoplasms; Vinblastine | 1970 |
Comparison of the dose- and timesurvival curves for normal hematopoietic and lymphoma colony-forming cells exposed to vinblastine, vincristine, arabinosylcytosine, and amethopterin.
Topics: Animals; Cell Line; Cytarabine; Female; Hematopoiesis; Lymphoma; Male; Methotrexate; Mice; Radiation Effects; Time Factors; Vinblastine; Vincristine | 1969 |
Cytosine arabinoside (NSC-63878) given subcutaneously to patients with cancer.
Topics: Adolescent; Adult; Aged; Blood Cell Count; Child; Cytarabine; Female; Humans; Injections, Subcutaneous; Leukemia; Lymphoma; Male; Middle Aged | 1969 |